EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Biology, Geography & Health: Chapter 35436

Chapter 35436 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.





Rovang, K.S.; Arouni, A.J.; Mohiuddin, S.M.; Tejani, A.; Hilleman, D.E., 2000:
Oral estrogen replacement therapy reduces the diagnostic accuracy of exercise stress tests in women

Vivian, J.A.; Thomas, B.W.; Majersky, L.S.; Yount, I.L.; Grant, K.A., 2001:
Oral ethanol self-administration and circadian measures of temperature and activity in monkeys

Birkle, D.L.; Roberts, A.J.; Moffitt, H.L.; Brennan, M.; Koob, G.F., 2000:
Oral ethanol self-administration on a progressive ratio schedule

Offner, H.; Matejuk, A.; Zamora, A.; Vandenbark, A.A.; Subramanian, S., 2003:
Oral ethinyl estradiol inhibits recruitment of inflammatory cells into the CNS and treats relapsing EAE


Giltay, E.J.; Gooren, L.J.; Emeis, J.J.; Kooistra, T.; Stehouwer, C.D., 2000:
Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men

Alici, S.; Saip, P.; Eralp, Y.; Aydiner, A.; Topuz, E., 2003:
Oral etoposide in platinum-resistant epithelial ovarian cancer

Millicovsky, G.; Sista, S.; Albert, K., 2001:
Oral exposure in dermal studies Confounding factor in drug safety evaluation

Kim, S.; Johnson, V.J.; Sharma, R.P., 2003:
Oral exposure to inorganic mercury alters T-lymphocyte phenotypes and cytokine gene expression in BALB/c mice

Wise, S.B.; Stock, D.W., 2003:
Oral expression of bmp2 and bmp4 orthologs in dentally divergent fishes

Mattes, R.D., 1999:
Oral fat exposure raises postprandial plasma triacylglycerol concentration

Calvert, J.R.chard; Rowlands, M.O.ar; Hobbs, M.A.thony, 2004:
Oral feeding bottle

Majeed, N.; Blouin, M.J.se; Agarwal, R.; Greenberg, N.; Pollak, M., 2003:
Oral feeding of silibinin reduces in vivo prostate cancer incidence and circulating IGF-I in the TRAMP transgenic model

Manhart, N.N.; Vierlinger, K.V.; Spittler, A.S.; Boltz Nitulescu, G.B.; Bergmeister, H.B.; Roth, E.R., 2000:
Oral feeding with glutamine prevents the endotoxin-caused B-cell diminution Peyers patches of mice

Esquivel Pedraza, L.; Fernandez Cuevas, L.; Ruiz Badillo, A.; Ortiz Mondragon, R.; Mejia Barrientos, F.; Chavana Barquin, E.; Magis Rodriguez, C., 2000:
Oral findings among prisoners in Mexico A pilot study

Loevenich, H.; Keulertz, C.; Schuett Gerowitt, H.; Bethe, U.; Soehngen, D.; Waldschmidt, D.; Cornely, O.A., 2001:
Oral flora and mucositis grade during myeloablative chemotherapy

Plosker, G.L.; Figgitt, D.P., 2003:
Oral fludarabine

Cazin, B.; Maloum, K.; Divine, M.; Lepretre, S.; Travade, P.; Delmer, A.; Jaubert, J.; Lederlin, P.; Dreyfus, B.; Leporrier, M.; Harousseau, J.L.; Grosbois, B.; Maloisel, F.; Eghbali, H.; Dumontet, C.; Benichou, J., 2001:
Oral fludarabine and cyclophosphamide in previously untreated CLL Preliminary data on 59 pts

Cazin, B.; Binet, J.L.; Divine, M.; Lepretre, S.; Lederlin, P.; Travade, P.; Lemaire, G.; Guibon, O., 2000:
Oral fludarabine and cyclophosphamide in previously untreated chronic lymphocytic leukemia Preliminary data

Cazin, B.F.; Maloum, K.; Creteil, M.D.vine; Lepretre, S.; Travade, P.; Delmer, A.; Jaubert, J.; Lederlin, P.; Dreyfus, B.; Leporrier, M.; Harousseau, J.L.c; Grosbois,, 2003:
Oral fludarabine phosphate and cyclophosphamide in previously untreated CLL Final response and follow-up in 75 patients

Zinzani, P.L.igi; Musuraca, G.; Stefoni, V.; Marchi, E.; Tani, M.; Alinari, L.; Gabriele, A.; Baccarani, M., 2003:
Oral fludarabine/cyclophosphamide combination in pretreated indolent non-Hodgkins lymphomas

Sangha, Jangbir S., 2002:
Oral fluid collection device and collection method

Razvi, F.M.; Kritzinger, E.E.; Taylor, K.; Jones, S.; Ryder, R.E.J., 1999:
Oral fluorescein angiography as an additional tool in diabetic retinopathy screening

Razvi, F.M.; Kritzinger, E.E.; Tsaloumas, M.D.; Ryder, R.E.J., 2000:
Oral fluorescein angiography in diabetic retinopathy screening

Lewis, N.L.; Meropol, N.J., 2000:
Oral fluoropyrimidines in cancer treatment

Van Cutsem, E.; Peeters, M., 2000:
Oral fluoropyrimidines in colorectal cancer

Porschen, R., 2003:
Oral fluoropyrimidines in the treatment of colorectal carcinoma

Reid, G.; Habash, M.; Vachon, D.; Denstedt, J.; Riddell, J.; Sofer, M.; Beheshti, M., 2000:
Oral fluoroquinolone therapy results in drug adsorption onto ureteral stents and prevention of biofilm formation

Stuehlinger, M.C.; Paulweber, B.; Schirnhofer, J.; Pachinger, O.; Stanger, O., 2004:
Oral folic acid does not reduce plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in hyperhomocysteinemic subjects

Armada, E.; Otero, A.; Perez, C.; Esteban, J.; Gayoso, P.; Camba, M.; Vazquez, D., 2002:
Oral folic acid is more efficient than oral and intravenous folinic acid for the treatment of hyperhomocysteinemia in HD patients

Holm, T.; Holven, K.; Aukrust, P.; Christensen, B.; Brosstad, F.; Andreassen, A.K.; Ose, L.; Gullestad, L.; Kjekshus, J.; Nenseter, M.S., 2000:
Oral folic acid treatment improves endothelial function in patients with hyperhomocysteinemia

Goede, J.; Hettche, H.; Momberger, H.; Engel, J.; Lobisch, M., 2003:
Oral forms of administration containing solid flupirtine with controlled release of active substance

Joshi, R.; Gore, A.Y.; Rubinfeld, J.; Shrotriya, R., 2001:
Oral formulation for paclitaxel

Sakr, A.A.el; Habib, W.A.del Azim, 1999:
Oral formulation for treatment of bacteria-induced diseases of the colon

Burman, A.C.; Mukherjee, R.; Khattar, D.; Kumar, M., 2003:
Oral formulation of methylglyoxal and its imino acid conjugates for human use

Feng, F.Y.; Zhang, P.; He, Y.J.an; Li, Y.H.ng; Zhou, M.Z.en; Cheng, G.; Chen, Y.; Kikkawa, T.; Yamamoto, M., 2002:
Oral formulations of the selective serotonin3 antagonists ramosetron and granisetron hydrochloride in treating acute chemotherapy-induced emesis, nausea, and anorexia A multicenter, randomized, single-blind, crossover, comparison study

Bosch, A.M.; Prick, L.; Ter Horst, N.M.; Van Gennip, A.H.; Wanders, R.J.A.; Duran, M.; Bakker, H.D.; Wijburg, F.A., 2002:
Oral galactose loading does not affect clinical or biochemical parameters in classical galactosemia

Szer, J.; Durrant, S.T.; Schwarer, A.P.; Bradstock, K.F.; Arthur, C.; Kilvington, R.; Australasian Bmt Cooperative Study Group, 1999:
Oral ganciclovir after allogeneic bone marrow transplants Preliminary results from a randomized study

Mouly, S., J.; Aymard, G.; Urien, S., S.; Diquet, B., S.; Bergmann, J.F.ancois, S.; Caulin, C., S., 1999:
Oral ganciclovir intestinal absorption is maintained in HIV-infected patients with diarrhea and weight loss

Firpi, R.J.; Bhardwaj, G.; Nelson, D.R.; Soldevila, C.; Reed, A.; Davis, G.L., 1999:
Oral ganciclovir monotherapy in the prevention of cytomegalovirus disease in liver transplant recipients

Tarshis, G.; Miskin, B.M.; Jones, T.M.; Champlin, J.; Wingert, K.; Brown, M.J.; Breen, J., 1999:
Oral gatifloxacin , 400 mg QD, vs oral levofloxacin , 500 mg QD, in the treatment of uncomplicated skin and soft tissue infections

Hariprasad, S.M.; Mieler, W.F.; Orengo Nania, S.; Holz, E.R.; Bell, N.P.; Gross, R.L., 2003:
Oral gatifloxacin a novel treatment paradigm for the management of filtering bleb infection

Saikawa, T.; Ooie, T.; Takahashi, N.; Nawata, T.; Arikawa, M.; Yamanaka, K.; Hara, M.; Sakata, T., 2001:
Oral geranylgeranylacetone induces heat shock protein and produces protection against ischaemia/reperfusion injury in rat heart

Kreitman, R.; Malley, A.; Klinger, E., 2002:
Oral glatiramer acetate treatment reduces EAE clinical signs in monkeys

Aharoni, R.; Sela, M.; Arnon, R., 2002:
Oral glatiramer acetate treatment results in the accumulation of specific Th2 cells in the central nervous system of mice

Ketteler, J.; Bauer, K.; Hellwig, M.; Versmold, H., 2002:
Oral glucose before venepuncture in neonates reduced pain expression but did not attenuate the increase in O2-consumption and heart rate

Hoenig, M.; Jordan, E.T.; Ferguson, D.C.; de Vries, F., 2010:
Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats

Fujimoto, K.; Hozumi, T.; Watanabe, H.; Tokai, K.; Shimada, K.; Muro, T.; Yoshiyama, M.; Takeuchi, K.; Homma, S.; Yoshikawa, J., 2003:
Oral glucose loading suppresses coronary flow velocity reserve on transthoracic Doppler echocardiography in healthy young adults

Garcia, R.L.; Garcia, C.E.; Vieira, J.G.; Parise, E.R., 2002:
Oral glucose overload test identifying insulin resistance in non-alcoholic fatty liver patients

Frier, H.I.; Greene, H.L.; Kaye, W.A.; Florez, A., 2002:
Oral glucose tolerance and the glycemic index of liquid meal replacements Preliminary results

Cure Cure, C.; Cure Ramirez, P.; Hernandez Cassis, C.; Vergel, C.; Lopez Jaramillo, P., 2003:
Oral glucose tolerance test 1 hour value has a strong association with cardiovascular risk factor in Colombian population

Ekman, B.; Nystrom, F.; Lindstrom, T.; Olsson, A.G.; Toss, G.; Arnqvist, H.J., 2000:
Oral glucose tolerance test is valuable for monitoring diabetogenic effects of GH-substitution

Grande, L.; Camacho, I.; Benitez, S.; Romero Gomez, M., 2002:
Oral glutamine challenge correlates with minimal hepatic encephalopathy and predicts overt episodes

Romero Gomez, M.; Grande, L.; Camacho, I.; Benitez, S.; Suarez, E.; Castro, M., 2001:
Oral glutamine challenge in patients with subclinical hepatic encephalopathy

Panigrahi, P.; Horvath, K.; Gewolb, I.H., 1999:
Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage

Todorova, V.K.; Kaufmann, Y.; Hennings, L.; Klimberg, V.Suzanne., 2010:
Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats

Walsh, N.P.; Blannin, A.K.; Bishop, N.C.; Robson, P.J.; Gleeson, M., 1999:
Oral glutamine supplementation does not attenuate the fall in human neutrophil function following prolonged exercise

Komninou, D.; Richie, J.P.Jr, 2000:
Oral glutathione inhibits colon carcinogenesis in rats

Goff, J.P.; Horst, R.L., 2001:
Oral glycerol as an aid in the treatment of ketosis/fatty liver complex

Pinthus, J.H.; Gavish, Z.; Ramon, J.; Leibovitch, I.; Esshar, Z.; Pines, M., 2000:
Oral halofuginone prevents the growth of human prostate cancer in SCID mice

Bassey, G.O.; Anyanechi, C.E.; Ekabua, K.J.; Ekabua, J.E., 2010:
Oral health among antenatal care attendees in Calabar, Nigeria

Park, S.M.; Frohna, J.G.; D.F.nseca, M.A., 2003:
Oral health care for children A community needs assessment

Mello, A.Lúcia.Schaefer.Ferreira.de.; Erdmann, A.Lorenzini.; Brondani, M., 2010:
Oral health care in long-term care facilities for elderly people in southern Brazil: a conceptual framework

Ortiz, K.A.; Castillo, J.; Hoff, C.J.; Buchi, K.F.; Byington, C.L., 2003:
Oral health habits of toddlers in a county clinic

Domett, K.M., 1999:
Oral health in Southeast Asia

Navas P.Rita; D.M.rales, T.R.jas; Zambrano, O.; Alvarez, C.J.lia; Santana, Y.; Viera, N., 2002:
Oral health in pre-school children Its relation to parental attitudes and educational level

Milgrom, P.; Reisine, S., 2000:
Oral health in the United States: the post-fluoride generation

Terpenning, M.; Shay, K., 2002:
Oral health is cost-effective to maintain but costly to ignore

Simons, D.; Kidd, E.A.; Beighton, D., 1999:
Oral health of elderly occupants in residential homes

Alberth, Márta.; Kovalecz, G.; Nemes, J.; Máth, János.; Kiss, C.; Márton, Ió.J., 2004:
Oral health of long-term childhood cancer survivors

Geltman, P.L.; Cote, S.E.; Nunn, M.E.; Lituri, K.; Barnett, E.D.; Garcia, R.I., 2003:
Oral health of newly arrived refugees in Massachusetts, 2000-2002

Lewis, C.W.; Riedy, C.A.; Domoto, P.K.; Grossman, D.C., 2001:
Oral health of young Alaska Native children and their mothers A population based study

Churchill, S.; Lissy, K.; Delecki, C.; Williams, B.; Villareale, N., 2004:
Oral health risk differences in children with public and private health insurance

Kyriakopoulos, G.; Katsourakis, M.; Aga Koumpitska, E.; Mavropoulou, E., 2000:
Oral health status of haemodialysis patients

Hiebert, L.M.; Wice, S.M.; Ping, T., 1999:
Oral heparin absorption in rats and humans

Carneiro, M.A.; Souza, L.N.; Azevedo, W.M.; Kalopothakis, E.; Victoria, J.M.N.; Gomez, R.S., 2000:
Oral herpes and bone marrow transplantation

Delgado, W.; Meneses, L.; Gotuzzo, E.; Flores, G., 2002:
Oral histoplasmosis in seropositive and seronegative HIV patients

Maestrejuan, A.; Meldrum, M.; Mccabe, E.R.B., 2002:
Oral history of human genetics project

Kadri, N.; Lemay, A.; Dodin, S.; Turcot, L.; Dechene, F.; Forest, J.C., 2001:
Oral hormone replacement therapy but not flaxseed supplementation improves serum cholesterol profile in hypercholesterolemic menopausal women

Wagner, Eugene C., 2000:
Oral hygiene appliance

Stier, R.E.; Zanone, J., 2001:
Oral hygiene compositions which mask the burn sensation and the astringency of eucalyptol and zinc

Kaminski, Basia, 2001:
Oral hygiene device

Yudelman, Clifford A., 1999:
Oral hygiene device having plaque collection and quantification capabilities

Lesky, J.; Lesky, J.; Lesky, T., 2003:
Oral hygiene formulation and method of use

Kholodova, H.; Shinkevich, T.; Karlovich, I., 2000:
Oral hygiene in diabetes mellitus patients

Anderson, Michael R., 2003:
Oral hygiene powder composition and method

Dimopoulos, M.; Panayiotidis, P.; Grigoraki, V.; Poziopoulos, C.; Xilouri, I.; Kiamouris, C.; Tassidou, A.; Gika, D.; Stefanoudaki, K.; Anagnostopoulos, N.; Anagnostou, D., 2001:
Oral hyperfractionated cyclophosphamide and intermittent thalidomide-dexamethasone for previously treated patients with multiple myeloma

Mannel, M.; Koytchev, R.; Dundarov, S., 2000:
Oral hypericum extract LI 160 is an effective treatment of recurrent herpes genitalis and herpes labialis

Matsushima, M., 2002:
Oral hypoglycemic agent How to interpret the results of UKPDS for Japanese?

Langer, O.; Conway, D.; Berkus, M.; Xenakis, E.M.J., 1999:
Oral hypoglycemic agent is comparable to insulin in GDM management A randomized study

Nalysnyk, L.; Ross, S.D., 2001:
Oral hypoglycemic agents in NIDDM A systematic literature review and MetaMap database

Oba, K., 2001:
Oral hypoglycemic agents in the treatment of elderly diabetics

Ruëff, F.; Eberlein-König, B.; Przybilla, B., 2001:
Oral hyposensitization with celery juice

Mclachlan, S.; Murray, R.; Bell, R.; Bergstrom, B., 2004:
Oral ibandronate an effective, well-tolerated and convenient alternative to intravenous bisphosphonates for patients with breast cancer and bone metastases

Teksam, O.; Yigit, S.; Karagoz, T.; Korkmaz, A.; Yurdakok, M.; Tekinalp, G., 2004:
Oral ibuprofen and intravenous indomethacin for treatment of patent ductus arteriosus in newborn infants retrospective study

Raeder, J.C.; Steine, S.; Vatsgar, T.T., 2001:
Oral ibuprofen versus paracetamol plus codeine for analgesia after ambulatory surgery

Lerzo, G.; Campos, C.; Vicente, H., 1999:
Oral idarrubicina and im methotrexate in patients with previously treated advanced breast cancer

Cameron, D.A.; Afseth, J.; Murray, E.; Bowman, A.; Leonard, R.C.F., 2002:
Oral idarubicin and capecitabine A dose-finding study confirms this as a safe, effective 1st line therapy for older women with breast cancer

Musso, M., 1999:
Oral idarubicin in maintenance therapy of acute myeloid leukaemia

Glasmacher, A.; Gorschlueter, M.; Hahn, C.; Goldschmidt, H.; Mezger, J.; Heyll, A.; Maintz, C.; Clemens, M.R.; Haferlach, T.; Derichs, R.; Ko, Y.; Schmidt Wolf, I.G.H.; Gieseler, F., 1999:
Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma Final analysis of a phase II study

Israeli, E.; Goldin, E.; Hemed, N.; Thalenfeld, B.; Engelhardt, D.; Rabbani, E.; Ilan, Y., 2003:
Oral immune regulation using colitis extracted proteins a new mode of treatment for crohns disease results of a phase i clinical trial

Safadi, R.; Israeli, E.; Pappo, O.; Gotsman, I.; Klein, A.; Alper, R.; Rowe, M.; Thalenfeld, B.; Engelhardt, D.; Rabbani, E.; Ilan, Y., 2000:
Oral immune-regulation towards hepatitis B virus proteins A new mode of treatment for chronic HBV infection Results of a phase I clinical trial

Kang, B.S.; Yahikozawa, H.; Palma, J.P.; Kim, B.S., 1999:
Oral immunity provides most efficient protection against TMEV-induced demyelination

Banerjee, S.; Medina Fatimi, A.; Nichols, R.; Tendler, D.; Michetti, M.; Mach, M.; Simon, J.; Kelly, C.P.; Monath, T.P.; Michetti, P., 2000:
Oral immunization against H pylori in healthy volunteers with low dose E coli enterotoxin and recombinant urease

Lauterslager, T.G.M.; Hilgers, L.A.T., 2000:
Oral immunization by food is less effective than intragastric immunization

Walters, N.; Rognlie, M.C.; Ascon, M.A.; Pascual, D.W., 2000:
Oral immunization of bison with an attenuated Salmonella vaccine vector induces mucosal and systemic immune responses against enterotoxigenic Escherichia coli K99 fimbriae

Salome,G.; Gowda,P.H.R., 2010:
Oral immunization of mice with rabies vaccine using different baits

Wedemeyer, H.; Gagneten, S.; Davis, A.R.; Feinstone, S.M.; Rehermann, B., 2000:
Oral immunization with HCV-NS3 encoding Salmonella Long-lasting induction of HCV-specific CTL in an HLA-A2 transgenic mouse model

Flanagan, M.P.; Michael, J.G., 1999:
Oral immunization with a Streptococcal pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharides

Hickey, D.K.; Aldwell, F.E.; Beagley, K.W., 2010:
Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection

Pinto, E.F.; Gattass, C.R.; Rodrigues, J.M.Jr.; Rossi Bergmann, B., 1999 :
Oral immunization with leishmanial antigens delays the onset of infection with L amazonensis

Rose, R.C.; Williamson, A.L.se; Rybicki, E.P., 2000:
Oral immunization with papillomavirus virus-like particles

Arntzen, C.J.; Mason, H.S.; Haq, T.A., 2001:
Oral immunization with transgenic plants

Pozzilli, P., 1999:
Oral immunotherapy for diabetes prevention

Bier, Milan, 2000:
Oral immunotherapy of bacterial overgrowth

Mcguinness, C.M.; Burnside, B.A.; Rudnik, E.M., 1999:
Oral induction of tolerance to parenterally administered non-autologous polypeptides

Carnoy, C.; Muller Alouf, H.; Mullet, C.; Droy Lefaix, M.T.; Simonet, M., 2000:
Oral infection of mice with superantigenic toxin producing Yersinia pseudotuberculosis Effect of diosmectite

Trees, A.J.; Mcallister, M.M.; Guy, C.S.; Smith, R.; Williams, D.J.L., 2002:
Oral infection of pregnant cows with Neospora caninum oocysts

Liesenfeld, O.; Maletz, A.; Erb, K.; Hahn, H., 2000:
Oral infection with Toxoplasma gondii abrogates established Th-2 immune responses to Nippostrongylos brasiliensis

Lalla, E.; Lamster, I.B.; Spessot, A.L.; Lu, Y.; Papapanou, P.N.; Stern, D.M.; Schmidt, A.M.rie, 2000:
Oral infection with an established periodontal pathogen accelerates atherosclerosis in apo E null mice

Gibson, F.C.I.i; Hong, C.; Wang, J.; Genco, C.A., 2002:
Oral infection with invasive Porphyromonas gingivalis stimulates accelerated atherosclerotic plaque accumulation in ApoE-/- mice

Doerflinger, A.; Davis, R.J.; Swithers, S.E., 2000:
Oral infusions of corn oil emulsions do not affect independent ingestion in rat pups

Carrithers, J.A.; Gallagher, P.M.; Baier, S.M.; Trappe, S.W., 1999:
Oral ingestion of beta-hydroxy-beta-methylbutyrate Effects on hematology, hepatic and renal function

Darveau, Richard P., 2000:
Oral innate host defense responses Interactions with microbial communities and their role in the development of disease

Richardson, G.; O'byrne, S.; Mcknight, G.; Moore, K.; Benjamin, N., 2000:
Oral inorganic nitrate inhibits platelet function

Lewin, A.; Modi, P., 2000:
Oral insulin Metformin combination therapy for treatment of type-2 diabetes

Kapitza, C.; Arbit, E.; Abbas, R.; Goldberg, M.; Hompesch, M.; Heinemann, L.; Heise, T., 2003:
Oral insulin Proof of concept in Type 2 diabetic patients

Modi, P.; Guevara Aguirre, J.; Guevara, M.; Saavedra, J.; Moncayo, P.; Benitez, E.; Llore, L.; Baldeon, G., 2002:
Oral insulin spray as meal insulin for treatment of Type 1 diabetes

Schwaibold, H.E.; Popiel, C.; Geist, E.; Hartung, R., 2000:
Oral intake of poppy seed A reliable and simple method for diagnosis of vesicoenteric fistulas

Beilharz, M.W.; Bosio, E.; Seidler, A.L., 2001:
Oral interferon therapy and the innate/acquired axis

Grady, R.W.; Giardina, P.J., 1999:
Oral iron chelation A potential role for HBED in combination therapy

Pippard, M.J.; Weatherall, D.J., 2000:
Oral iron chelation therapy for thalassaemia: an uncertain scene

Bell, H.; Berg, J.P.; Undlien, D.; Distante, S.; Try, K.; Raknerud, N.; Heier, H.E.; Thomassen, Y.; Haug, E., 2000:
Oral iron intake for several years may induce hemochromatosis in patients without the HFE-gene C282Y mutation

Carrier, J.; Elaheh, A.; Cullen, J.; Allard, J.P., 2000:
Oral iron supplementation increase oxidative stress and colonic damage in DSS-induced rat model of colitis

D.S.lva, A.D.; Rampton, D., 2002:
Oral iron therapy does not exacerbate inflammatory bowel disease

Bachman, T.A.; Clare, T.; Serbinski, A., 2000:
Oral irrigator housing

Bettoli, V.; Borghi, A.; Pizzigoni, S.; D.S.nctis, V.; Virgili, A., 2004:
Oral isotretinoin for severe acne in beta-thalassemia major

Geraldine, P.; Kaliamurthy, J.; Thomas, P.A., 1999:
Oral itraconazole and fluconazole treatment for experimental aspergillosis

Namburi, R.R.ju; Kerr, J.E.gin, 2003:
Oral itraconazole formulations and methods of making the same

Chosidow, O.; Giraudeau, B.; Cottrell, J.; Izri, A.; Hofmann, R.; Mann, S.G.; Burgess, I., 2010:
Oral ivermectin versus malathion lotion for difficult-to-treat head lice

Kapur, N.; Friedman, R., 2002:
Oral ketamine: a promising treatment for restless legs syndrome

Romach, M.K.; Sellers, E.M.; Kaplan, H.L.; Fernandes, L.C.; Oldenhof, J.; Mcdonald, S., 2004:
Oral ketamine as a positive control in abuse liability studies

Vranken, J.H.; Pijl, A.J.; Van Der Vegt, M.R.; Eshuis, J.E., 2001:
Oral ketamine in patients with central pain

Coussons Read, M.E.; Tyler, R.C., 2000:
Oral l-arginine supplementation affects circulating cytokine levels and stress reactivity

Dunn, S.R.; Simenhoff, M.L.; Gaughan, W.J.; Eltayeb, B.O.; Ahmed, K.E.; Fitzpatrick, M.E.len D., 2000:
Oral lactobacillus acidophilus reduces blood levels of dimethylamine , a uremic toxin, and nitrosodimethylamine , a carcinogen in ESRD patients Potential use for probiotics in ESRD

de Castro, C.; Quirce, S.; Fernández-Nieto, M.; Sastre, J., 2002:
Oral latex glove allergy

Kalayoglu Besisik, S.; Ak, G.; Koray, M.; Savran Oguz, F.; Sargin, D.; Tanyeri, H., 2003:
Oral lesions and hygiene in stem cell recipients with graft versus host disease

Ramirez Amador, V.; Irigoyen, M.E.; Esquivel Pedraza, L.; Anaya Saavedra, G.; Gonzalez Ramirez, I.; D.L.R.sa Garcia, E.; Gonzalez Guevara, M., 2000:
Oral lesions in a group of Mexican individuals attending an HIV Screening Center

Patel, N.J.; Sciubba, J., 2003:
Oral lesions in young children

Lasko, B.; Lau, C.Y.; Anstey, R.J.; StPierre, C.; Martel, A.Y.; Diaz Mitoma, F.; Canadian Collaborative Sinusitis Study Group, 1999:
Oral levofloxacin compared with clarithromycin in acute sinusitis

Chaiyarit, P.; Kafrawy, A.H.; Miles, D.A.; Zunt, S.L.; Van Dis, M.L.; Gregory, R.L., 1999:
Oral lichen planus An immunohistochemical study of heat shock proteins and cytokeratins and a unifying hypothesis of pathogenesis

Kolde, G.; Wesendahl, C.; Stein, H.; Reichart, P.A., 2003:
Oral lichen planus: diagnostic immunofluorescence testing on routine histological material

Ido, T.; Kumakiri, M.; Kiyohara, T.; Sawai, T.; Hasegawa, Y., 2002:
Oral lichen planus due to zinc in dental restorations

Pecegueiro, M.; Sachse, M.F.; Amaro, J.; Farinha, P.; Fonseca, I., 1999:
Oral lichen planus versus oral lichenoid eruption as a manifestation of contact allergy

Auzerie, V.; Mahé, E.; Marck, Y.; Auffret, N.; Descamps, V.; Crickx, B., 2001:
Oral lichenoid eruption due to methacrylate allergy

Akihiro, Yoshiaki, 2003:
Oral lip and chin muscle rehabilitating device

Keller, Brian C., 2004:
Oral liposomal delivery system

Skrabanja, A.T.tus Philip; Tully, R.E.ward, 2000:
Oral liquid antidepressant solution

Wilson, E.S.; Trespidi, L.A.; Clark, C.M.; Desai, A.J.; Meyer, G.A., 2001 :
Oral liquid compositions

Bahal, S.M.; Maurin, M.B., 2001:
Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors

Tully, Roger Edward, 2000:
Oral liquid medicine solution

Dobrozsi, Douglas Joseph, 2003:
Oral liquid mucoadhesive compositions

Dobrozsi, Douglas Joseph, 2001:
Oral liquid mucoadhesive compounds

Kobayashi, R.; Zemlin, M.; Kataoka, K.; Zemlin, C.; Schelonka, R.; Dimmitt, R.; Hino, A.; Schroeder, H.W.J.; Mcghee, J.R.; Fujihashi, K., 2003:
Oral live r-Salmonella expressing fragment C of tetanus toxin induces antigen-specific IgA responses in mice with limited Igh variable region diversity

Boriani, G.; Martignani, C.; Biffi, M.; Capucci, A.; Branzi, A., 2002:
Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment

Hunter, C.M.; Gaffar, A.; Mordarski, T.D., 2000:
Oral lubricating composition

Wang, T.; Steel, G.; Valle, D., 2001:
Oral lysine supplementation reduces plasma ornithine in a mouse model of gyrate atrophy of the choroid and retina

Zehender, M.; Faber, T.S.; Manz, M.; Susilo, R., 2001:
Oral magnesium and potassium treatment of frequent ventricular tachyarrhythmias Lessons from the MAGICA trial

Standley, C.; Daugherty, M.; Lohff, J., 2001:
Oral magnesium does not alter brain levels of ionized magnesium in pregnant rats

Chagas, E.H.; Kelly, D.G.; Camilleri, M.; Burritt, M.F., 2003:
Oral magnesium gluconate increases urinary mg2+ in patients with short bowel syndrome

Wang, F.; Van Den Eeden, S.; Ackerson, L.; Salk, S.; Reince, R., 2000:
Oral magnesium oxide prophylaxis of frequent childhood migraine

Shechter, M.; Merz, C.N.el Bairey; Stuhlinger, H.S.; Sharir, M.; Matezki, S.; Pachinger, O.; Slany, J.; Rabinowitz, B., 2001:
Oral magnesium supplementation improves exercise duration and quality of life in patients with coronary artery disease

Shechter, M.; Bairey Merz, C.N.; Paul Labrador, M.; Meisel, S.R.; Molloy, M.D.; Rude, R.K.; Shah, P.K.; Kaul, S., 1999:
Oral magnesium treatment inhibits platelet-dependent thrombosis in patients with coronary artery disease

Shirley, J.C.; Thornton, J.B., 2000:
Oral manifestations of Langerhans' cell histiocytosis: review and report of case

Sierevogel, M.J.; Pasterkamp, G.; Velema, E.; D.K.eijn, D.P.V.; D.S.et, B.J.G.L.; D.J.egere, P.P.T.; Borst, C., 1999:
Oral matrix metalloproteinase inhibition following balloon angioplasty in a non-atherosclerotic pig model

Bartholomaeus, J.; Betzing, J., 2001:
Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates

Palumbo, A.; Bertola, A.; Musto, P.; Nunzi, M.; D.S.efano, V.; Callea, V.; Rotoli, B.; Petti, M.C.; Caravita, T.; Lauta, V.M.; Patti, C.; Bringhen, S.; Cavallo, F.; Falco, P.; Carella, A.M.; Liberati, A., 2003:
Oral melphalan, Prednisone and Thalidomide for newly diagnosed myeloma

Woo, J.S.o; Suh, H.J.o, 2002:
Oral micro-emulsion composition of silybin

Desoto, J.S.garra; Torres, R.V.zquez; Rodriguez Duran, A., 1999:
Oral microbiota of bats

Johnson, T.N.; Rostami Hodjegan, A.; Tucker, G.T., 2002:
Oral midazolam for sedation in children A pharmacokinetic-pharmacodynamic analysis

Millet, C.; Ogden, F.; Lutz, B., 2000:
Oral minocycline without long-term intravenous antibiotics for treatment of prosthetic joint infections

Delaney, T.; Crane, J.M.; Hutchens, D.; Fanning, C.A.; Young, D.C., 2001:
Oral misoprostol labor induction in patients with a favorable cervix

Crane, J.; Delaney, T.; Hutchens, D., 2002:
Oral misoprostol labor induction in term prelabor membrane rupture

Tortora, G.; Damiano, V.; Bianco, R.; Fontanini, G.; Caputo, R.; Bianco, A.R.; D.P.acido, S.; Agrawal, S.; Ciardiello, F., 1999:
Oral mixed-backbone oligonucleotide targeting protein kinase A causes inhibition of growth, angiogenesis and growth factor production and cooperative antitumor activity with cytotoxic drugs in human cancer xenografts

Stark, P.; Cunningham, S.; Moodley, J., 2000:
Oral morphine multiparticulate formulation

Braddock, B.A.; Braddock, S.R.; Maria, B.L., 2003:
Oral motor findings in Joubert syndrome

Solomon, B.I.; Mccullagh, L.; Krasnewich, D.; Smith, A.C.M.; Sms Research Unit, 2002:
Oral motor, speech and voice functions in Smith Magenis Syndrome children A research update

Rakhmatov, T.P.; Irsaliev, K.I., 2001:
Oral mucosa in patients with lichen ruber planus

Hannu, L.; Markku, V.; Pekka, V.; Stina, S.; Markku, M., 2000:
Oral mucosa responds by recruitment and non-proliferative activation of T cells after submucosal challenge with a gliadin derived peptide

Buser, Thomas, 2001:
Oral mucosal composition comprising 5-aminosalicylic acid

Zhang, H.; Zhang, J.; Streisand, J.B., 2002:
Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications

Stancliff, S.; Abel, S.; Agins, B., 2001:
Oral mucosal lesions and HIV viral load in the Womens Interagency HIV Study

Epstein, J.B.; Schubert, M.M., 1999:
Oral mucositis in myelosuppressive cancer therapy

Durrant, S.; Pico, J.L.is; Ford, J.M., 2001:
Oral mucositis reduced health related quality-of-life in a phase 1 trial of lymphoma patients receiving high-dose chemotherapy with autologous PBPC transplantation

Oldenburg, B.; Van Berge Henegouwen, G.P.; Koningsberger, J.C., 1999:
Oral mycophenolate mofetil in the treatment of inflammatory bowel disease

Lima Júnior, S.Monteiro.; Asprino, L.; Prado, A.Pedro.; Moreira, R.Willian.Fernandes.; de Moraes, Márcio., 2010:
Oral myiasis caused by Cochliomyia hominivorax treated nonsurgically with nitrofurazone: report of 2 cases

Terg, R.; Coronel, E.; Sorda, J.; Findor, J., 2000:
Oral naltrexone treatment for cholestatic pruritus A randomized, double blind, crossover study

Jakobi, P.; Solt, I.; Weiner, Z.; Zimmer, E.Z.Z., 1999:
Oral narcotic and non-narcotic analgesia after cesarean section

Fujita, T.; Kosugi, K.; Ueda, N.; Hatano, M., 2001:
Oral nateglinide administration improves glycemic control of type 2 diabetic patients, treated with intermediate-acting insulin

Iliodromitis, E.K.; Bofilis, E.; Zoga, A.; Steliou, I.; Vrettou, R.; Cokkinos, P.; Kremastinos, D.T.H., 2002:
Oral nicorandil recaptures the waned protection of preconditioning in vivo

Liu, R.; Mizuta, M.; Ueno, H.; Shiiya, T.; Suefuji, M.; Matsukura, S., 2001:
Oral nicotine administration decreases insulin resistance in obese rats

Wilmouth, C.; Spear, L.P., 2002:
Oral nicotine self-administration in rats during adolescence

Cook, T.A.; Smilgin Humphreys, M.M.; Mortensen, N.J.M.c, 1999:
Oral nifedipine effectively reduces resting anal pressure A potential new treatment for anal fissures

Dawood A.W.ili, N.S.; A.J.bouri, K.Y., 2001:
Oral nifedipine in the treatment of primary tonic clonic epilepsy

Reitz, Aé.; Knapp, P.A.; Müntener, M.; Schurch, B., 2004:
Oral nitric oxide donors: a new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients?

Reitz, A.; Knapp, P.; Schurch, B., 2003 :
Oral nitric oxide for treatment of detrusor-sphincter dyssynergia in spinal cord injured patients

Tamaki, T.; Kirima, K.; Okamoto, M.; Kondo, S.; Kagami, S.; Yoshizumi, M.; Tsuchiya, K., 2003:
Oral nitrite increases the blood nitric oxide levels and protects L-name-induced renal injury in rats

Pongsiriwet, S.; Iamaroon, A.; Mahanupab, P.; Kitikamthon, R.; Pintong, J., 2002:
Oral non-Hodgkins lymphomas p53 expression and lack of EBV expression

Edington, J.; Hollingsworth, M.; Rhoades, L.; Campbell, S.; Ferguson, M.; Mayer, K.; Voss, A., 2002:
Oral nutritional supplement flavour preferences of weight-losing patients with cancer

Verma, S.; Kirkwood, B.; Brown, S.; Giaffer, M.H., 2001:
Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease

Nugent, A.G.; Wolthers, T.; Kam, G.; Leung, K.C.; Garrett, C.; Ho, K.K.Y., 2000:
Oral oestrogen opposes the growth hormone -induced rise in extracellular water

Alemany, M.; Grasa, M.M.; Esteve, M.; Masanes, R.M.; Yubero, P.; Blay, M.; Lopez Marti, J.; Cabot, C.; Vila, R.; Fernandez Lopez, J.A.; Remesar, X., 2000:
Oral oleoyl-estrone effects on insulin resistance of Zucker obese rats

Alemany, M.; Fernandez Lopez, J.A.; Petrobelli, A.; Granada, M.; Foz, M.; Remesar, X., 2002:
Oral oleoyl-estrone-induced loss of weight in a morbidly obese man

Lagranderie, M.; Chavarot, P.; Balazuc, A.M.; Marchal, G., 1999:
Oral or intragastric administration of BCG induced immune responses and protection against tuberculosis

Lowell, George H., 1999:
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides

Cunha, B.A., 2001:
Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia

Von Falkenhausen, Christian, 2003:
Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use

E.Rafaey, Hazem, 2003:
Oral or vaginal administration of mesoprostol in third stage labor

Tielemans, W.M.J., 2002:
Oral orthesis to reduce snoring and sleep apnea symptoms

Reeda, C.F.; Markwell, P.J.; Jones, C.A.; Mayer, R.J.; Smith, B.H.E., 2000:
Oral orthophosphate salt administration, and its effect on feline urinary calcium oxalate formation and agglomeration

Hayden, F.G.; Ward, P.; Roberts, N., 2000:
Oral oseltamivir in experimental human influenza B virus infection Lack of resistance emergence

Hayden, F.; Belshe, R.; Villanueva, C.; Lanno, R.; Small, I.; Hughes, C.; Dutkowski, R., 2002:
Oral oseltamivir prevents the spread of influenza between children in households

Kurowski, M.; Barrett, J.; Waalberg, E.; Wiltshire, H., 2000:
Oral oseltamivir rapidly delivers active drug levels to middle ear and sinuses in humans

Kaiser, L.; Ward, P.; Mahoney, P.; Hayden, F.G., 2001:
Oral oseltamivir reduces complications and hospitalizations resulting from influenza infection A meta-analysis

Winther, B.; Hayden, F.G.; Whitley, R.; Reisinger, K.; Dutkowski, R.; Ipe, D.; Ward, P.; Mills, R., 2000:
Oral oseltamivir reduces the risk of developing acute otitis media following influenza infection in children

Puthli, S.P.; Menon, S.G.; Karajgi, J.S.; Dharmadhikari, N.B.; Shrivastava, R.H.; Pilgaonkar, P.S., 2003:
Oral osmotic controlled drug delivery system for a sparingly soluble drug

Grover, J.; Caravati, E.M., 2000:
Oral overdose of N-acetylcysteine in an infant

Just, T.; Steiner, S.; Pau, H.W., 2010:
Oral pain perception and taste in burning mouth syndrome

Iglesias Garcia, J.; Iglesias Garcia, M.; Iglesias Rey, M.; Dominguez Munoz, E., 2003:
Oral pancreatic enzyme supplementation in patients with exocrine pancreatic insufficiency is it enough to evaluate clinical response?

Pisegna, J.R.; Forsmark, C.E.; Soffer, E.; Bochenek, W.J.; Metz, D.C., 2000:
Oral pantoprazole effectively controls gastric acid output in Zollinger-Ellinson syndrome and idiopathic hypersecretion

Metz, D.C.; Forsmark, C.E.; Soffer, E.; Bochenek, W.J.; Pisegna, J.R., 2000:
Oral pantoprazole effectively maintains control of acid output in Zollinger-Ellison syndrome and idiopathic hypersecretion

Richter, J.; Bochenek, W., 1999:
Oral pantoprazole treatment decreases antacid usage in patients with symptomatic erosive esophagitis

Shen, W-Chiang., 2003:
Oral peptide and protein delivery: unfulfilled promises?

Stern, W.; Gilligan, J.P., 2000:
Oral peptide pharmaceutical products

Sachs, G.; Dietrich, R., 2000:
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Sachs, G.; Dietrich, R., 2000:
Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Valenti, Mauro, 2002:
Oral pharmaceutical compositions containing buprenorphin

Aylwin, E.A.ne; Banbury, S.; Ferdinando, J.J.an Christine; D.N.js, H., 2003:
Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants

Depui, H.; Rosinski, A., 2000:
Oral pharmaceutical dosage form

Depui, H.; Lundberg, P., 2003:
Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID

Depui, H.; Hallgren, A., 2000:
Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent

Depui, H.; Hallgren, A., 2001:
Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate

Midha, K.K.; Hirsh, M.; Lo, W.Y.ng, 2002:
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent

Birrenbach, G.; Juch, R.D.eter, 1999:
Oral pharmaceutical preparation containing erythromycin base

Mockel, J.; Gabel, R.D.eter; Woog, H., 2000:
Oral pharmaceutical preparation containing ibandronat

Chen, G.L.n; Hsu, W.Y., 2001:
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same

Lundberg, P.J.han; Sjoblom, B., 2003:
Oral pharmaceutical pulsed release dosage form

Winegarden, K.L.; Ciesla, S.L.; Aldern, K.A.; Beadle, J.R.; Hostetler, K.Y., 2002:
Oral pharmacokinetics and preliminary toxicology of 1-O-hexadecyloxypropyl-cidofovir in mice

Trahan, J.; Ciesla, S.L.; Winegarden, K.L.; Hostetler, K.Y., 2003:
Oral pharmacokinetics and tissue distribution of 1-O-hexadecyloxypropyl- cyclic cidofovir in mice

Sharma, V.K.; Spears, T.; Peyton, B.; Raufman, J.P.erre; Howden, C.W., 2000:
Oral pharmacokinetics of lansoprazole after single and multiple doses as intact capsule and as simplified lansoprazole suspension

Ho, J.C.; Meier, J.L.; Lopez, J.R.; Cunningham, F.; Swislocki, A.L.M.; Noth, R.H.; Siegel, D., 2002:
Oral pharmacological treatment of type 2 diabetes mellitus in veterans

Burnett, A.L., 1999:
Oral pharmacotherapy for erectile dysfunction: current perspectives

Brock, Gerald, 2000:
Oral phentolamine

Domrongkitchaiporn, S.; Disthabanchong, S.; Cheawchanthanakij, R.; Niticharoenpong, K.; Stitchantrakul, W.; Charoenphandhu, N.; Krishnamra, N., 2010:
Oral phosphate supplementation corrects hypophosphatemia and normalizes plasma FGF23 and 25-hydroxyvitamin D3 levels in women with chronic metabolic acidosis

McCarty, M.F.; Barroso-Aranda, J.; Contreras, F., 2010:
Oral phycocyanobilin may diminish the pathogenicity of activated brain microglia in neurodegenerative disorders

Arroyave, C.P.; Scott, I.U.; Fernandez, V., 2003:
Oral pilocarpina for dry eye in sjogrens syndrome

Angulo, P.; Maccarty, R.L.; Sylvestre, P.B.; Jorgensen, R.A.; Larusso, N.F.; Lindor, K.D., 2000:
Oral pirfenidone in the treatment of primary sclerosing cholangitis

Oguchi, S.; Nosaka, T.; Nagao, K.; Satou, K.; Yumi, K.; Watanabe, I.; Yamashita, M.; Watanabe, M.; Shioiri, K.; Kikushima, K.; Arima, K.; Arima, K., 1999:
Oral platelet glycoprotein IIb/IIIa antagonist decreased intimal thickening after arterial injury in hypercholesterolemic apolipoprotein E knockout mice

Kereiakes, D.J., 1999:
Oral platelet glycoprotein IIb/IIIa inhibitors

Sawyer, M.H.; Saez Llorenz, X.; Aviles, C.L.z; O'ryan, M.; Romero, J.R., 1999:
Oral pleconaril reduces the duration and severity of enteroviral meningitis in children

Anonymous, 2000:
Oral poliovirus was not the source of HIV-1

Cesaretti, M.L.R.; Ginoza, M.; Shiguehara, F.; Kohlmann, N.E.B.; Tavares, A.; Zanella, M.T.; Ribeiro, A.B.; Kohlmann, O., 2000:
Oral potassium overload reduces blood pressure and improves glucose metabolism in spontaneously hypertensive rats

García-Lerma, J.Gerardo.; Paxton, L.; Kilmarx, P.H.; Heneine, W., 2010:
Oral pre-exposure prophylaxis for HIV prevention

Sudbo, J.; Kildal, W.; Sondresen, J.E.; Ristimaki, A.; Nesland, J.M.; Reith, A.; Bryne, M., 2002:
Oral precancer Risk assessment in a chemopreventive perspective

Caon, C.; Ching, W.; Tselis, A.; Lisak, R.; Khan, O., 2003:
Oral prednisone taper has no effect on neurologic recovery following intravenous methylprednisolone for the treatment of an MS relapse

Million, M.; Wang, L.; Maryanov, T.; Coutinho, S.; Mayer, E.; Tache, Y., 2001:
Oral pregabalin reduces repeated colorectal distention -induced visceral pain and lumbosacral spinal cord neuronal activation in rats

Varma, A.K., 1999:
Oral premalignant lesions in rural Indian inhabitants

Spong, C.; Vink, J.; Auth, J.; Gozes, I.; Brenneman, D., 2001:
Oral prenatal treatment with peptides increases adult performance in a learning paradigm

Cremer, Karsten, 2001:
Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium

Stoilov, I.L.bomirov; Georgiev, T.D.mitrov; Taskov, M.V.silev; Koleva, I.D.mitrova, 1999:
Oral preparation for patients with chronic renal insufficiency, method of making and use

Wadstrom, T.; Alejung, P., 2001:
Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp infection

Ren, G.; Fei, G., 2003:
Oral preparation of coenzyme a useful for lowering blood lipid and a method producing for same

Murata, M.; Saito, Y.; Kanbe, H.; Yamauchi, S.; Iwasa, A., 2002:
Oral preparations comprising S- -L-cysteine

Komuro, C.; Yahiro, T.; Yoshida, H., 2002:
Oral preparations containing forskolin derivatives and process for producing pharmaceutical preparations

Brooke, A.E.; Eveson, J.W.; Luker, J.; Oakhill, A., 1999:
Oral presentation of a novel variant of herpes simplex infection in a group of bone marrow transplant patients: a report of five cases

Ray, N.B.; Krieg, A.M., 2001:
Oral pretreatment of mice with immunostimulatory CpG DNA induces reduced susceptibility to Listeria monocytogenes

Stewart, R.A.; Pelican, K.M.; Brown, J.L.; Wildt, D.E.; Ottinger, M.A.; Howard, J.G., 2010:
Oral progestin induces rapid, reversible suppression of ovarian activity in the cat

Villani, G.Q.; Piepoli, M.F.; Marrazzo, N.; Rosi, A.; Capucci, A., 2001:
Oral propafenone cost-effectiveness in patients with recent onset atrial fibrillation

Peterson, K.S.; Sherman, J.M.; Chilcott, C.; Wu, T.C.ong, 2001:
Oral prophalaxis paste

Meggs, W.J.; Freeman, J.M.Jr, 1999:
Oral prophylaxis of organophosphate poisoning in mice

Bagnis, C.; Berutti, S.; Vitale, C.; Marangella, M.; Tricerri, A.; Bruno, M.; Petrarulo, M.; Ramello, A., 2002 :
Oral protein supplements in CAPD Medium term evaluation of nutritional markers

Holm, L.; Esmarck, B.; Suetta, C.; Matsumoto, K.; Mizuno, M.; Kjaer, M., 2003:
Oral protein/carbohydrate increases muscle protein balance following resistance exercise in postmenopausal women

Vocks, E.; Fornoff, N.; Rakoski, J.; Ring, J., 2001:
Oral provocation test with fragrances in fragrance-sensitized subjects

Giehtbrock, K.; Flynn, S.; Andrist, D.; Mccready, L.; Frigas, E., 1999:
Oral provocation testing with common dyes and preservatives used by the food industry Our experience over the last five years

Vieluf, D.; Wieben, A.; Ring, J., 1999:
Oral provocation tests with food additives in atopic eczema

D.V.sser, M.; Van Der Meulen, M.F.G.; Hoogendijk, J.E.; Burger, H.; Wokke, J.H.J., 2001:
Oral pulsed dexamethasone or prednisone for idiopathic inflammatory myopathies Prospective long-term follow-up in 16 patients

Burnside, B.A.; Guo, X.; Fiske, K.; Couch, R.A.; Treacy, D.J.; Chang, R.K.n; Mcguinness, C.M.; Rudnic, E.M., 2003:
Oral pulsed dose drug delivery system

Hernández-Martín, A.; Arias-Palomo, D.; Hermida, G.; Gutiérrez-Ortega, M.C.; Ramírez-Herrera, M.; Rodríguez-Vegas, M.; Velasco, A., 2003:
Oral pyoderma gangrenosum

Sun, G.Y.; Xu, J.; Zhang, Z.; Shen, S.; Von Borstel, R.W.; Saydoff, J.A., 2000:
Oral pyrimidine treatment protects against neuronal loss in the gerbil stroke model

Saydoff, J.A.; Liu, L.S.; Von Borstel, R.W., 2000:
Oral pyrimidine treatment protects mice against striatal damage and behavioral impairment induced by 3-nitropropionic acid

Williamson, L.; Illingworth, H.; Smith, D.; Mowat, A., 2000:
Oral quinine in ankylosing spondylitis: a randomized placebo controlled double blind crossover trial

King, R.; Yakobson, B.; David, D.; Zamir, S.; Linhart, S.B.; Naveh, U.; Fridman, J., 2000:
Oral rabies vaccination of wildlife in Israel

Waksman, R.; Ajani, A.E.; Pichard, A.D.; Pinnow, E.; Satler, L.F.; Kent, K.M.; Weissman, N.J.; Torguson, R.; Gambone, L.; Abbott, M.; Iloanya, P.; Lindsay, J., 2003:
Oral rapamune to inhibit restenosis in patients with multi de-novo coronary lesions requiring stenting

Pakala, R.; Burnett, M.S.san; Gulick, C.P.; Fournadjiev, J.; Leborgne, L.; Cheneau, E.F.; Hellinga, D.; Epstein, S.E.; Waksman, R., 2003:
Oral rapamycin attenuates progression of atherosclerotic plaque in ApoE knockout mice

Mehran, R.; Marx, S.; Kesanakurthy, S.; Adamian, Y.; Aboufares, A.; Moussa, I.; Kokolis, S.; Collins, M.; New, G.; Polena, S.; Cosico, J.; Lansky, A.J.; Moses, J.W.; Stone, G.W.; Leon, M.B.; Dangas, G., 2003:
Oral rapamycin for the prevention of in-stent restenosis

Rodriguez, A.E.; Rodriguez Alemparte, M.; Fernandez Pereira, C.; Vigo, C.F.; Llaurado, C.; Russo Felsen, M.; Pocovi, A.; Vetcher, D., 2004:
Oral rapamycin in patients undergoing coronary stent therapy Final results of the ORAR Study

Tyler, K.R.; Venkova, K.; Keith, J.C.Jr.; Albert, L.; Greenwood Van Meerveld, B., 2001:
Oral recombinant human interleukin-11 normalizes epithelial transport in the colon of HLA-B27 rats with spontaneous colitis

Van Scott, M.; Glynn, P.; Varadhachary, A., 2004:
Oral recombinant human lactoferrin in a non-human primate model of asthma

Huang, Chang Lung, 2003:
Oral rehabilitation device

Guarino, A., 2000:
Oral rehydration for infantile diarrhoea: toward a modified solution for the children of the world

Michell, A.R., 2010:
Oral rehydration: measuring what matters

Santosham, M., 2002:
Oral rehydration therapy: reverse transfer of technology

Anidi, Ifeoma E., 2000:
Oral rehydration therapy in diarrhea Parental knowledge and practices

Bellemare, S.; Hartling, L.; Wiebe, N.; Russell, K.; Craig, W.; Klassen, T.P., 2002:
Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children A systematic review

Ozuah, P.O.; Avner, J.R.; Stein, R.E.K., 2001:
Oral rehydration, practice parameters, and emergency physicians A national survey

Matsumoto, T.; Taguchi, Y.; Fujita, K.; Ametani, A.; Kaminogawa, S.; Nakagami, M., 2000:
Oral remedy for rheumatoid arthritis and functional food

Fujiu, K.; Manabe, I.; Oishi, Y.; Tsushima, K.; Nishimura, G.; Nagai, R., 2003:
Oral retinoic acid receptor alpha agonist inhibits in-tent restenosis

Kligerman, A.E.; Rogers, S., 2002:
Oral rinse methods and compositions

Volkow, N.D.; Wang, G.J.; Fowler, J.S.; Gerasimov, M.R.; Gatley, J.S.; Gifford, A.; Logan, J.; Pappas, N.; Wong, C.; Franceschi, M.; Dewey, S.L.; Ding, Y.S.; Franceschi, D., 2000:
Oral ritalin increases dopamine concentration in human brain

Kuiken, S.; Van Den Berg, S.; Tytgat, G.; Boeckxstaens, G., 2003:
Oral s ketamine increases visceral sensitivity in healthy volunteers

Khoury, S.J.; Comabella, M.; Weiner, H.L., 1999:
Oral salbutoamol decreases interleukin-12 expression in monocytes of patients with multiple sclerosis

Stern, W.; Gilligan, J.P., 1999:
Oral salmon calcitonin pharmaceutical products

Fabian, T.J.; Ujhelyi, M.R.; Schwartzman, D.S.; Bigos, K.L.; Corey, S.E.; Kroboth, P.D., 2003:
Oral sedation improves patient perception of shock delivery with an implantable atrial defibrillator

Masini, C.V.; Maki, A.C.; Baek, J.H.; Spires, S.S.; Holmes, P.V., 2003:
Oral self - administration of amphetamine is increased in the olfactory bulbectomized rat model of depression

Knippels, L.M.J.; Penninks, A.H.; Houben, G.F., 1999:
Oral sensitization to food proteins A Brown Norway rat food allergy model

Knippels, L.M.J.; Van Wijk, F.; Penninks, A.H., 2000:
Oral sensitization to peanut proteins A Brown Norway rat food allergy model

Grainger, B.T.; Kleinhenz, R.J.; Christensen, G.W., 2002:
Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof

Pierce, A.; Koumans, E.; Sawyer, M.; Akers, C.; Black, C.; Markowitz, L., 2001:
Oral sex as an indicator of high risk behavior

Michelakis, E.D.; Tymchak, W.; Lien, D.; Dasilva, L.; Hashimoto, K.; Archer, S.L., 2002:
Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension

Kaplan, B.; Ben-Rafael, Z.; Peled, Y.; Bar-Hava, I.; Bar, J.; Orvieto, R., 1999:
Oral sildenafil may reverse secondary ejaculatory dysfunction during infertility treatment

Zelek, L.; Barthier, S.; Riofrio, M.; Sevin, D.; Spielmann, M., 2000:
Oral single-agent estramustine is active in advanced breast cancer after failure with anthracyclines and taxanes

Teirstein, P.S.; Moses, J.W.; Fernandez, M.R.; Brara, P.; Grise, M.A.; Moussavian, M.; Reilly, J.P.; Leon, M.B., 2002:
Oral sirolimus for recalcitrant in-stent restenosis

Hausleiter, J.; Kastrati, A.; Mehilli, J.; Schuehlen, H.; Dotzer, F.; Goos, C.; Pogatsa Murray, G.; Vogeser, M.; Breuer, M.; Dirschinger, J.; Schoemig, A.; The Osiris Study Group, 2004:
Oral sirolimus to inhibit recurrent in-stent stenosis The randomized, double-blind, placebo-controlled OSIRIS trial

Costantini, C.R.; Zanuttini, D.; Tarbine, S.; Darwich, R.; Lazarte, J.L.; Costantini, C.O.; Maranhao, M.; Andrade, M.; Oliveira, M.R.; Sabattini, L.; Yared, G.; Bub, 2003:
Oral sirolimus to prevent restenosis after stenting de novo coronary lesions

Calhoun, D.A.; Renfroe, K.; Alper, A.B., 2000:
Oral sitaxsentan, an endothelin-A selective receptor antagonist, reduces systemic blood pressure in patients with mild-to-moderate primary hypertension

Kajimoto, O.; Sakamoto, W.; Odanaka, W.; Yoshida, K., 2003:
Oral skin improving agent, skin improving method, and food composition for improving skin

Curran, M.P.; Plosker, G.L., 2004:
Oral sodium phosphate solution: a review of its use as a colorectal cleanser

Schanz, S.; Kruis, W.; Mickisch, O.; Kueppers, B.; Hornung, A.; Buch Noethe, S.; Clement, T.; Boerner, N.; Berg, P., 2003:
Oral sodium phosphate solution versus polyethylene glycol based lavage for bowel preparation for colonoscopy a multicenter trial

Roser, B.J.; Blair, J.; Colaco, C.; Hatley, R.H.nry Morris, 1999:
Oral solid dosage forms, methods of making same and compositions thereof

Schiavino, D.; Buonomo, A.; Del Ninno, M.; Roncallo, C.; Pollastrini, E.; Camerini, A.; Nucera, E.; Patriarca, G., 2001:
Oral specific desensitization and immunologic modifications in 4 children with milk allergy

Cavallo, M.G.; Coppolino, G.; Romeo, S.; Manfrini, S.; Modi, P.; Pozzilli, P., 2001:
Oral spray insulin in patients with type 1 diabetes Comparison with regular insulin

Cavallo, M.G.; Coppolino, G.; Romeo, S.; Modi, P.; Parravano, M.C.; Pozzilli, P., 2001:
Oral spray insulin in patients with type 1 diabetes and residual beta cell function

Brandwein, M.; Teixeira, M.; Rolnitzky, L.; Lewis, C.; Lee, B.; Urken, M.; Wang, B., 2003:
Oral squamous carcinoma Invasion pattern and margin status correlate with locoregional recurrence

Gelman Keiles, D.; Lozada Nur, F., 2000:
Oral squamous cell carcinoma Where is the delay in diagnosis occurring?

Bernstein, K.S.; Schelling, S.H., 1999:
Oral squamous cell carcinoma in a coyote

Griff, J., 2001:
Oral steroids and inflammatory markers in asthma

Fucile, S.; Gisel, E.; Lau, C., 2002:
Oral stimulation accelerates the transition from tube to oral feeding in preterm infants

Hagiwara, Hidenori, 2002:
Oral stimulator

Dijkgraaf Ten Bolscher, M.; Neele, S.J.M.; Barto, R.; Netelenbos, J.C.; Van Der Vijgh, W.J.F., 2000:
Oral strontium as a test for intestinal calcium absorption Variation, validation, application

Rajendran, R., 2000:
Oral submucous fibrosis An Asiatic enigma

Frucht, H.; Movsas, B.; Hanlon, A.L.; Goosenberg, E.; Hoffman, J.; Cooper, H.; Lanciano, R.; Lee, W.R.; Schultheiss, T.; Hanks, G.E., 1999:
Oral sucralfate reduces the late GI effects of conformal RT for prostate CA A double-blind placebo-controlled randomized trial

Oberlander, T.F.; Grunau, R.E.; Hiddink, F.; Maaskant, R.; Fitzgerald, C.E.; Ling, E.; Whitfield, M.F., 2002:
Oral sucrose in the preterm infant Analgesic or behavioral modifier?

E.H.ddad, M.; Ross, M., 2001:
Oral sucrose stimulates ingestive behavior in near term ovine fetus

Cavallaro, L.G.; Moussa, A.M.; Caruana, P.; Merli, R.; Bertolini, S.; Iori, V.; Cavestro, G.M.; Muzzetto, P.; Liatopoulou, S.; Dal Bo, N.; D.M.rio, F., 2003:
Oral sucrose test and serum pepsinogens for evaluation of H pylori chronic gastritis

Gambaro, G.; DiN.A.S.G.oup, 2000 :
Oral sulodexide reduces albuminuria in type 1 and type 2, micro- and macro-albuminuric diabetic patients The DiNAS trial

Keith, A.D.; Gaisford, K.N.; Miller, A.H., 2004:
Oral supplement composition containing a plurality of mushroom strains

Chez, M.G.; Tremb, R.J.; Zenchak, J., 2001:
Oral supplementation of beta-hydroxybutyrate in rats

Van Weerden, W.M.; D.R.dder, C.M.; Bolder, C.A.; Wildhagen, M.; Kraemer, K.; Schroder, F.H., 2003:
Oral supplementation of vitamin E and lycopene reduces orthotopic growth of PC-346C prostate tumors

Turck, D.; Schmelmer, V., 2001:
Oral suspension of pharmaceutical substance

Wöhrl, S.; Hemmer, W.; Focke, M.; Götz, M.; Jarisch, R., 2001:
Oral symptoms due to zinc as a minor component of dental amalgam

Meer, S.; Coleman, H.; Altini, M., 2003:
Oral synovial sarcoma A report of two cases and a review of the literature

Berkhoudt, H.; D.B.kker, M.A.G.; Zweers, G.A., 2001:
Oral taste buds in the rattlesnake

Yu, D.; Walker, P.S.; Tang Liu, D., 2004:
Oral tazarotene does not affect the pharmacokinetics or efficacy of oral contraceptives

Tellier, G.; Lasko, B.; Leroy, B.; Sidarous, E.; Andrade, C., 2000:
Oral telithromycin for 5 days and 10 days is well tolerated and as effective as amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis in adults

Deabate, C.A.; Heyder, A.; Leroy, B.; Sidarous, E.; Backstrom, J., 2000:
Oral telithromycin for 5 days is well tolerated and as effective as cefuroxime axetil for 10 days in adults with acute exacerbations of chronic bronchitis

Ziter, P.; Quinn, J.; Leroy, B.; Sidarous, E.; Belker, M., 2000:
Oral telithromycin for 5 days is well tolerated and as effective as clarithromycin for 10 days in group A beta-hemolytic streptococcal pharyngitis/tonsillitis

Pullman, J.; Leroy, B., 2002:
Oral telithromycin for 7 to 10 days is as effective as standard comparators for the treatment of community-acquired pneumonia

Van Rensburg, D.; Moola, S.; Hagberg, L.; Rangaraju, M.; Leroy, B., 2001:
Oral telithromycin for 7-10 days is as effective as standard comparators for the treatment of community-acquired pneumonia

Pullman, J.; Champlin, J.; Leroy, B.; Sidarous, E., 2000:
Oral telithromycin for 7-10 days is well tolerated and as effective as oral trovafloxacin for 7-10 days in community-acquired pneumonia in adults

Tellier, G.; Hassman, J.; Leroy, B.; Sidarous, E.; Youngblood, D., 2000:
Oral telithromycin is well tolerated and as effective as oral clarithromycin in community-acquired pneumonia in adults

D.Berker, D., 2001:
Oral terbinafine treatment for toenail onychomycosis

Lefever, S.L.; Reddy, U.P.; Babaliaros, V.C.; Lewis, W.L.nce; Blau, N.; Harrison, D.G.; Block, P.C.; Quyyumi, A.A., 2003:
Oral tetrahydrobiopterin reduces blood pressure and improves endothelial function in hypertensive patients

Lebovitz, H.E., 2001:
Oral therapies for diabetic hyperglycemia

Michael, J.G.briel; Litwin, A., 2001:
Oral therapy for the treatment of allergies and method of manufacture

Schultz, M.; Cunningham Rundles, S.; Lehn, N.; Falk, W.; Schoelmerich, J., 1999:
Oral therapy with Lactobacillus GG alters the immune response towards Bacteroides sp

Schultz, M.; Cunningham Rundles, S.; Lehn, N.; Falk, W.; Scholmerich, J., 1999:
Oral therapy with lactobacillus GG alters the activation response of PBMC and CD4 T-lymphocytes towards Bacteroides sp

Schultz, M.; Cunningham Rundles, S.; Lehn, N.; Falk, W.; Scholmerich, J., 1999:
Oral therapy with lactobacillus GG alters the proliferative response of PBMC and CD4 T-lymphocytes towards Bacteroides sp

Schulman, S., 2000:
Oral thrombin inhibitors

Kimball, S.D., 1999:
Oral thrombin inhibitors Challenges and progress

Dutta, A.; Chari, P.; Mohan, R.A.; Manhas, Y., 2002:
Oral to nasal endotracheal tube exchange in a difficult airway: a novel method

Maron, R.; Faria, A.M.C.; Weiner, H.L., 1999:
Oral tolarogen generation in nude and B-cell knockout mice after feeding a high dose ovalbumin

Mayer, L., 1999:
Oral tolerance: new approaches, new problems

Guerau D.A.ellano, M.; Maron, R.; Weiner, H.L., 1999:
Oral tolerance and insulin and GAD peptide responses in cyclophosphamide induced diabetes in NOD mice

Spiekermann, G.M.; Walker, W.A., 2001:
Oral tolerance and its role in clinical disease

Strobel, S., 2001:
Oral tolerance and systemic immunoregulation

Caspi, Rachel R., 1999:
Oral tolerance and uveitis

Jones, D.E.J.; Palmer, J.M.; Yeaman, S.J.; Bassendine, M.F.; Kirby, J.A., 1999:
Oral tolerance as a potential therapy in primary biliary cirrhosis

Kato, H.; Fujihashi, K.; Kato, R.; Mcghee, J.R., 2000:
Oral tolerance blocks cholera toxin induced IgA responses

Ilan, Yaron, 2004:
Oral tolerance for treatment of GI inflammation

Song, F.; Campbell, K.A.; Benson, J.M.; Wardrop, R.M.; Gienapp, I.E.; Whitacre, C.C., 2002:
Oral tolerance in experimental autoimmune encephalomyelitis Sites for T cell activation and TCR downregulation in the GALT

Moldoveanu, Z.; Oliver, F.; Mestecky, J.; Elson, C.O., 2005:
Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration

Zhang, X.; Liu, L.; Oida, T.; Weiner, H.L., 2000:
Oral tolerance induces regulatory CD25+CD4+ T cells in ovalbumin TCR transgenic mice

Speciani, A.F.; Fasani, G.; Fumagalli, M.; Barbieri, G.; Gessati, A., 2001:
Oral tolerance induction by low-dose nickel solution Effective and safe treatment of nickel-induced eczema

Yasufuku, K.; Heidler, K.M.; Smith, G.N.; Cummings, O.W.; Wilkes, D.S., 2000:
Oral tolerance induction by type V collagen in lung transplantation

Postlethwaite, A.E.; Wheller, P.; Myers, L.; Kang, A., 2000:
Oral tolerance induction in mice treated with DMARDS

Thurau, S.R.; Diedrichs Mohring, M.; Fricke, H.; Burchardi, C.; Wildner, G., 1999:
Oral tolerance induction in uveitis patients using an HLA-peptide

Pansare, M.; Genyea, C.; Kaplan, J.; Secord, E., 2000:
Oral tolerance induction to anti-factor VIII antibody production in Balb/c mice

Prystupa, K.; Rudzki, E., 2000:
Oral tolerance of nickel in patients with dyshidrosis

Siqueira, A.; Jancar, S.; Foster, P.; Russo, M., 2001:
Oral tolerance prevents the development of airway hyperreactivity and Th2-associated allergic responses in prototypic murine models of asthma

Friedman, A.; Bar Shira, E.; Klipper, E., 2000:
Oral tolerance revisited Innocuous oral antigen induces immune responses in the absence of adjuvant in birds

Secord, E.A.; Pansare, M.; Gao, P.; Kaplan, J., 2001:
Oral tolerance to factor VIII antibody production in neonatal and young mice

Weiner, H.L.; Slavin, A.J.; Maron, R., 1999:
Oral tolerance to glatiramer acetate in MBP T cell receptor transgenic mice

Krause, I.; Blank, M.; Sherer, Y.; Bar Dayan, Y.; Shoenfeld, Y., 2000 :
Oral tolerance to low dose IVIG Immunomodulation of experimental APS

Kjaer, T.M.R.; Frokiaer, H., 1999:
Oral tolerance to ovomucoid is inhibited by simultaneously oral administration of a dietary plant lectin

Jones, D.E.; Palmer, J.M.; Yeaman, S.J.; Kirby, J.A.; Bassendine, M.F., 1999:
Oral tolerance to pyruvate dehydrogenase complex as a potential therapy in primary biliary cirrhosis

Angulo, P.; Van D.W.ter, J.; Gershwin, M.E.; Jorgensen, R.A.; Lindor, K.D., 2002:
Oral tolerance to pyruvate dehydrogenase for treatment of primary biliary cirrhosis A pilot study

Gotsman, I.; Beinart, R.; Safadi, R.; Rabani, E.; Engelhardt, D.; Shouval, D.; Gorecki, M.; Chwdhury, N.R.y; Chowdhury, J.R.y; Ilan, Y., 1999:
Oral tolerance towards hepatitis B antigens in a murine model

Nagler, A.; Gotsman, I.; Pines, M.; Rabbani, E.; Engelhart, D.; Ilan, Y., 1999:
Oral tolerance towards pretransplant antigens alleviates chronic graft versus host disease

Van Puijvelde, G.H.; Van Der Zee, R.; D.V.s, P.; Van Berkel, T.J.; Van Eden, W.; Kuiper, J., 2003:
Oral tolerance with heat shock protein 60 and a heat shock protein 60 peptide reduces atherogenesis

Strobel, S., 2002:
Oral tolerance, systemic immunoregulation, and autoimmunity

Baggi, F.; Andreetta, F.; Milani, M.; Caspani, E.; Simoncini, O.; Longhi, R.; Cornelio, F.; Mantegazza, R.; Antozzi, C., 1999:
Oral tolerization of EAMG in B6 mice by immunodominant epitope Talpha146-162

Brown, J.J.; Parashar, B.; Singh, A.; Rabbani, E.; Engelhardt, D.; Roy Chowdhury, N.; Roy Chowdhury, J., 2000:
Oral tolerization to hepatitis B virus proteins ameliorates hepatic inflammation in Tupaia carrying hepatitis B viral infection

O'malley, R.C.; Mcgrew, W.C., 1999:
Oral tool use among captive orang utans

Petroff, O.A.; Hyder, F.; Mattson, R.H.; Rothman, D.L., 1999:
Oral topiramate rapidly increases brain GABA in patients with epilepsy

Loos, W.J.; Sparreboom, A.; Verweij, J.; D.J.nge, M.J.A., 2000:
Oral topotecan in adults should not be dosed by body-surface area

Ozaki, M.; Takahara, T.; Kakiuchi, M.; Nakamura, K.; Yamaoka, R., 2001:
Oral toxicity of monoterpenes and appetite-reducing effects of their odors in the blowfly, Phormia regina

Welch, S.L., 2002:
Oral toxicity of topical preparations

Thanavala, Y.; Lugade, A.A., 2010:
Oral transgenic plant-based vaccine for hepatitis B

Baron, S.; Ganceres, N.; Nguyen, D.; Poast, J., 2001:
Oral transmission of HIV Biophysical vs molecular defenses in saliva

Acharya, R.N.; Baker, J.L., 2001:
Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity

Zhang, H.; Croft, J., 2001:
Oral transmucosal drug dosage using solid solution

Danjoux, C.; Chow, E.; Wong, R.; Connolly, R.; Andersson, L.; Franssen, E.; Stefaniuk, K.; Schueller, T.; Pope, J.; Szumacher, E.; Hayter, C., 2000 :
Oral transmucosal fentanyl citrate for incidental pain in radiotherapy patients An innovative approach

Noguera, M.A.; D'ocon, P.; Gisbert, R.; Miquel, R.; Anselmi, E.; Ivorra, M.D., 2003:
Oral treatment of spontaneously hypertensive rats with prazosin, nifedipine or captopril changes noradrenaline-sensitive internal Ca2+ stores in vessels

Lee, Y.W.; Overstreet, D.H.; Yang, Y.; Luan, Y.; Fang, Q.C., 1999:
Oral treatment with NPI-031G reduces alcohol intake in high alcohol drinking rats

Van Ginckel, R.; Floren, W.; Moelans, P.; Janssens, B.; Molenberghs, K.; Wouters, W., 1999:
Oral treatment with R101933 restores the sensitivity towards paclitaxel and adriamycin in resistant human tumors xenografted in athymic mice

Henriksen, E.J.; Johnson, K.W.; Kinnick, T.R.; O'keefe, M.P.; Harrison, S.D., 2001:
Oral treatment with a glycogen synthase kinase-3 inhibitor improves glucose tolerance and skeletal muscle glucose transport activity in Zucker Diabetic Fatty rats

Collins, S.M.; Galeazzi, F., 1999:
Oral treatment with ethanol aggravates experimental colitis in mice

Overstreet, D.H.; Yang, Y.; Du, Q.Z.; Lee, Y.W., 1999:
Oral treatment with kudzu extract reduces alcohol intake in high alcohol drinking rats

Hougee, S.; Vriesema, A.J.M.; Wijering, S.C.; Knippels, L.M.J.; Folkerts, G.; Nijkamp, F.P.; Knol, J.; Garssen, J., 2010:
Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study

Cunliffe, W.J.; Aldana, O.L.; Goulden, V., 1999:
Oral trimethoprim: a relatively safe and successful third-line treatment for acne vulgaris

Mathew, N.T.; Kailasam, J.; Fischer, A.S., 2001:
Oral triptans are effective and well-tolerated in migraine with neurological symptoms

Daniel, R.; Trovafloxacin Study Group, 1999:
Oral trovafloxacin compared with amoxicillin for the treatment of mild to moderate community-acquired pneumonia

Luke, D.R., 1999:
Oral trovafloxacin versus intravenous cefoxitin in elective hysterectomy

Peterson, J.; Trovafloxacin Study Group, 1999:
Oral trovafloxacin vs oral cefuroxime +- erythromycin in community-acquired pneumonia

Fabro, R.S.; Pelayo, A., 1999:
Oral tube holder

Molina, M.; Herrero, J.A.; Ortega, N.; Gomez, J., 2001:
Oral tuberculosis Epidemiologic factors, clinical course and outcome

Bernard, B.K.; Hoberman, A.M.; Brown, W.R.y; Ranpuria, A.K.; Christian, M.S., 2002:
Oral two-generation reproduction study of pentachlorophenol in rats

Christian, M.S.; York, R.G.; Hoberman, A.M.; Fisher, L.C.; Brown, W.R.y, 2002:
Oral two-generation reproductive toxicity study of bromodichloromethane in rats

Christian, M.S.; York, R.G.; Hoberman, A.M.; Frazee, J.; Fisher, L.C.; Brown, W.R.; Creasy, D.M., 2002:
Oral two-generation reproductive toxicity study of dibromoacetic acid in rats

Myers, L.K.; Higgins, G.; Thomson, J.; Walton, C.; Hendricks, J.; Kerr, N.; Pandya, P.; Shlopov, B.; Seyer, J.M.; Postlethwaite, A.E.; Kang, A.H., 1999:
Oral type II collagen in JRA

Orchard, T.R.; Vaughan, R.; Welsh, K.I.; Jewell, D.P., 1999:
Oral ulceration and polymorphisms of the MHC class I chain like gene A in peripheral arthropathies of inflammatory bowel disease

Garrigue, V.; Canet, S.; Dereure, O.; Panabieres, O.; Augias, D.; Chong, G.; Mourad, G., 2001:
Oral ulcerations in a renal transplant recipient: a mycophenolate mofetil-induced complication?

Syrjanen, S.; Leimola Virtanen, R.; Schmidt Westhausen, A.; Reichart, P.A., 1999:
Oral ulcers in AIDS patients frequently associated with cytomegalovirus and Epstein-Barr virus infections

Huang, G.S.; Yang, S.M.; Wang, C.B., 2000:
Oral uptake of chitosan inhibits growth of B16 melanoma in mouse

Goker, E.; Aykan, N.F.; Serdengecti, S.; Gunel, N.; Alakavuklar, M.; Icli, F.; Yucel, I.; Uskent, N.; Arpaci, F.; Firat, D., 1999:
Oral uracil/tegafur plus leucovorin in patients with metastatic colorectal cancer

Saydoff, J.A.; Liu, L.S.; Hu, Z.Y.; Noble, M.M.; Tandon, P.; Garcia, R.A.G.; Von Borstel, R.W., 2001:
Oral uridine prodrug PN401 protects mice against azide toxicity in vivo Studies on the mechanism of uridine neuroprotection in vitro

Hu, Z.Y.; Liu, L.S.; Tandon, P.; Brenneman, D.; Cardin, S.; Von Borstel, R.W.; Saydoff, J.A., 2002:
Oral uridine prodrug pn401 is neuroprotective in neuroinflammatory models of alzheimers disease

Venhoff, N.; Lebrecht, D.; Deveaud, C.; Beauvoit, B.; Bonnet, J.; Müller, K.; Kirschner, J.; Venhoff, A.C.; Walker, U.A., 2011:
Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues

Colburn, K.K.; Langga Sharifi, E.M.; Lee, M.L., 1999:
Oral use of intravenous immunoglobulin for the treatment of rheumatoid arthritis

Aldwell, F.E.; Buddle, B.M.; Tucker, I.M., 2002:
Oral vaccination against tuberculosis

Russell Jones, G.J.hn; Howe, P.; D.A.zpurua, H.J.mes; Rand, K.N.rman, 2000:
Oral vaccines

Hunter, R.L.; Bennett, C.E., 1999:
Oral vaccines comprising multiple emulsions and methods of preparation

Spruance, S.L.; Jones, T.M.; Blatter, M.M.; Vargas Cortes, M.; Barber, J.; Goldstein, D.; Schultz, M., 2002:
Oral valaciclovir for the treatment of herpes labialis Two trials of early, high-dose, short-course therapy

Aslanides, I.M.; D.S.uza, S.; Wong, D.T.W.; Giavedoni, L.R.; Altomare, F.; Detorakis, E.T.; Kymionis, G.D.; Pallikaris, I.G., 2002:
Oral valacyclovir in the treatment of acute retinal necrosis syndrome

Liesveld, J.L.; Abboud, C.N.; Lancet, J.; Ifthikharuddin, J.J.; Oliva, J.L.; Wedow, L.A.; Stamm, C.; Nichols, D., 2001:
Oral valacyclovir vs intravenous acyclovir in prevention of herpes simplex virus infections in autologous stem cell transplantation patients

von Kries, R., 1999:
Oral versus intramuscular phytomenadione: safety and efficacy compared

Dennison, J.D.vid; Quernin, M.H.; A.K.ndi, S.; Muralitharan, S.; Tauro, M.; Kanan, K.; Daar, S.; A.Z.djali, S.; Pathare, A.; Zia, F.; Nusrat, N.; U.R.hman, J.; Taqi, A.; Jacqz Aigrain, E.; Ganguly, S.S.ndar; Krishnamoorthy, R., 2003:
Oral versus intravenous busulfan in bone marrow transplantation for thalassemia

Mazess, R.B.; Elangovan, L., 2002:
Oral versus intravenous vitamin D hormone therapy in dialysis patients

Pinto, E.F.; Cortezia, M.M.; Lima, G.F.; Rodrigues Junior, J.M.; Rossi Bergmann, B., 2000:
Oral versus subcutaneous immunization with leishmanial Ag encapsulated in microspheres A new strategy for protection in murine leishmaniasis

Heyneman, C.A.; Lawless-Liday, C.; Wall, G.C., 2000:
Oral versus topical NSAIDs in rheumatic diseases: a comparison

Fisher, S.; Davies, G.; Mackenzie, P., 2001:
Oral versus vaginal misoprostol for induction of labour A double-blind, placebo-controlled randomised trial

Danielson, D.W.; Nichols, E.; Husband, B., 2000:
Oral veterinary composition containing a fluoroquinolone antibacterial agent possessing superior absorption properties and an extended duration of therapeutic antimicrobial blood levels, and a method of treating microbial infection in a ruminant

Miller, J.W.; Green, R.; Herbert, V.D.; Flynn, M.A., 1999:
Oral vitamin B12 supplementation decreases homocysteine in healthy elderly people with suboptimal vitamin B12 status

Campbell, A.K.L.mon; Miller, J.W.; Green, R.; Haan, M.N.; Allen, L.H., 2003:
Oral vitamin B12 supplements normalize plasma B12 and homocysteine, but have an insignificant effect on functional outcomes, in Latino elderly with marginal B12 status

Raitakari, O.T.; Adams, M.R.; Mccredie, R.J.; Griffiths, K.A.; Stocker, R.; Celermajer, D.S., 1999:
Oral vitamin C and endothelial function in smokers Acute improvement, but no sustained beneficial effect

Mak, J.C.S.; Stuart-Harris, J.; Cameron, I.D.; Mason, R.S., 2010:
Oral vitamin D replacement after hip fracture: a comparative review

Kuan, J.K.; Brock, G.B., 2003:
Oral vitamin E and folic acid supplementation during sildenafil therapy for erectile dysfunction improves salvage in non-responders

Cho, B.; Kim, H.K.; Kim, C.C.oo; Lee, J.W.ok, 1999:
Oral vitamin E and glutathione for the prevention and early treatment of veno-occlusive disease in children with acute leukemia undergoing hematopoietic stem cell transplantation

Wright, S.; Westland, G.; Jeffrey, R.R.; Watson, H.G., 2004:
Oral vitamin K does not affect vitamin K-dependent coagulation factors in normal individuals

Bond, S.; Rhodes, S.; Taylor, M.; Sansum, K.; Green, E.S., 2002:
Oral vitamin K for excessively anticoagulated patients who are not bleeding is safe and effective

Levitsky, J.; Ehrenpreis, E.D.; Jani, A.B.; Ahn, J.; Hong, J.J., 2003:
Oral vitamin a for the treatment of chronic radiation proctopathy a randomized, controlled trial

Schleuning, M.; Judith, D.; Thoedtmann, R.; Baurmann, H.; Schwerdtfeger, R., 2003:
Oral voriconazole for prophylaxis of fungal infections during allogeneic hematopoietic stem cell transplantation in patients at risk

Jehn, U.; Suciu, S.; Thomas, X.; Varet, B.; Muus, P.; Berneman, Z.; Marie, J.P.; Broccia, G.; Fillet, G.; Mandelli, F.; Nobile, F.; Ricciuti, F.; Leone, G.;, 2002:
Oral vs Intravenous Consolidation Chemotherapy in Elderly Patients with AML Results of the EORTC-GIMEMA AML-13 Phase III Trial

Bradley, J.S., 1999:
Oral vs. intramuscular antibiotic therapy for acute otitis media: which is best?

Paul, M.; Vidal, L.; Ben Dor, I.; Soares Weiser, K.; Leibovici, L., 2003:
Oral vs intravenous antibiotic treatment for febrile neutropenia A meta-analysis

Atherly John, Y.C.; Cunningham, S.J.; Senturia, Y.D.; Crain, E.F., 2001:
Oral vs intravenous rehydration in the pediatric emergency department

Tojimbara, T.; Kimikawa, M.; Nakajima, I.; Sato, S.; Nakamura, M.; Ishida, H.; Tanabe, K.; Koyama, I.; Utsumi, K.; Sannomiya, A.; Tsuji, K.; Fuchinoue, S.; Agishi, T., 1999:
Oral vs intravenous tacrolimus-based induction therapy in renal transplantation

Larsen, H.H.; Huang, L.; Kovacs, J.A.; Crothers, K.; Silcott, V.A.; Morris, A.; Turner, J.R.; Beard, C.B.; Masur, H.; Fischer, S.H., 2003:
Oral washes for diagnosis of Pneumocystis pneumonia in patients with HIV infection using quantitative touch-down PCR

Zapatero, L.; Martínez, M.I.; Alonso, E.; Salcedo, G.; Sánchez-Monge, R.; Barber, D.; Lombardero, M., 2003:
Oral wheat flour anaphylaxis related to wheat alpha-amylase inhibitor subunits CM3 and CM16

A.Hady, Essam M., 2000:
Oral zinc sulphate treatment and supplementation to cases of acrodermatitis enteropathica and severe protein enegy malnutrition specially kwashiorkor

Iwasaki, S.; Suzuki, R.; Nomura, K.; Hasegawa, T.; Ito, Y.; Yoshimura, A.; Ideura, T., 2001:
Oral zinc supplementation reduces mean erythropoietin dose in EPO-required hemodialysis patients

Beckman, N.; Houston, S.; Hentges, D.; Boudreau, N.; Ferguson, M.; Bender, S.; Voss, A., 2002:
Oral zinc supplementation, pressure ulcer development and healing in long-term care residents

Singer, R.; Tuchman, M.; Abu Shakra, S., 2003:
Oral zolmitriptan demonstrates high efficacy in the acute treatment of true menstrual migraine

Loder, E.; Silberstein, S.; Giammarco, R.; Smith, T.; Mueller, L.; Abu Shakra, S., 2002:
Oral zolmitriptan exhibits efficacy as early as 30 minutes in menstrually associated migraine Results of a large multicenter placebo-controlled study

Goadsby, P.J.; Gawel, M.; Hardebo, J.E.ik; Millson, D.; Bahra, A.; Breen, S., 1999:
Oral zolmitriptan is effective in the acute treatment of episodic cluster headache

Tuchman, M.; Abu Shakra, S.; Silberstein, S.D.; Dodick, D., 2003:
Oral zolmitriptan is efficacious as acute therapy for pure menstrual migraine Results of a second large prospective, multicenter, placebo-controlled Trial

Ferrero, G.B.; Valenzise, M.; Sorasio, L.; Franco, B.; Defilippi, C.; Pepe, E.; Silengo, M., 2001:
Oral, facial, digital, vertebral anomalies with psychomotor delay An OFD variant or a new syndrome?

Petersen, P., 2003:
Oral, fixed-dose ximelagatran, without dose titration or coagulation monitoring, is well tolerated and at least as effective as well-controlled warfarin

Dietrich, R.; Ney, H., 1999:
Oral-administration forms of a medicament containing pantoprazol

Toriello, Helga V., 2003:
Oral-facial-digital syndrome I

Rudenskaya, G.E.; Prityko, A.G.; Gonchakov, G.V.; Yasonov, S.A., 2000:
Oral-facial-digital syndrome type I

Ward, David M., 2001:
Oral-facial-digital syndrome type I unrecognised until age 46 in a woman diagnosed as adult-type polycystic kidney disease

Athanikar, Narayan, 2002:
Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases

Levitsky, G.; Colman, J.L.; Brown, S., 2002:
Oral/nasal cannula

Guevava, M.; Modi, P.; Guevara Aguirre, J.; Saavedra, J.; Baldeon, G.; Moncayo, P.; Llore, L.; Benitez, E., 2002:
Oralin as a meal insulin in treatment of Type 2 diabetes

Juturu, V.; Komorowski, J.R.; Gudi, R., 2004:
Orally Administered Arginine Silicate Inositol Complex Is Not Clastogenic In Chinese Hamster Ovary Cells

Hama, Susan H., 2004:
Orally Administered Statins and an ApoA-I Mimetic Peptide Act Synergistically to Render ApoE Null Mouse HDL Anti-inflammatory

Chen, C.; Wilcoxen, K.; Bozigian, H.; Chen, T.; Cha, M.; Mccarthy, J.R.; Huang, C.Q.; Haddach, M.; Zhu, Y.F.i; Murphy, B.; D.S.uza, E.B.; Grigoriadis, D.E., 2001:
Orally active 3- pyrazolo pyrimidines as nonpeptide CRF1 receptor antagonists

Blackburn, B.K.; Melville, C.; Zablocki, J.A.; Palle, V.P.; Elzein, E.O.; Wang, L., 2003:
Orally active A1 adenosine receptor agonists

Kitamura, S.; Fukushi, H.; Miyawaki, T.; Kawamura, M.; Terashita, Z.I.hi; Naka, T., 2001:
Orally active GPIIb/IIIa antagonists Synthesis and biological activities of masked amidines as prodrugs of 2- -4- -2- -3- propanoyl-3-

Loozen, H.J.n Jozef; Leysen, D.; Louw, J.V.n Der, 2004:
Orally active androgens

Chaudhary, S.; Puri, S.K.; Singh, C., 2003:
Orally active artemisinin derivatives

Posner, G.H.; Paik, I.H.; Mcriner, A.J.; Sur, S.; Borstnik, K.; Xie, S.; Shapiro, T.A., 2003:
Orally active artemisinin-derived trioxane dimers

Chin, A.P.; Bernhardt, P.V.; Richardson, D.R., 2003:
Orally active chelators for the treatment of iron overload diseases

Huggins, J.W.; Baker, R.O.; Beadle, J.R.; Hostetler, K.Y., 2002:
Orally active ether lipid prodrugs of cidofovir for the treatment of smallpox

Nag, B.; Medicherla, S.; Sharma, S.D., 2000:
Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes

Allaudeen, H.; Ramaswamy, M.; Radhakrishnan, B.; Rajagopalan, J.; Rajotte, R.V., 1999:
Orally active insulin A single insulin conjugate selected for future studies

Meyerhoff, C.; Stern, W.; Beer, B.; Ramaswamy, M.; Allaudeen, H., 1999:
Orally active insulin Proof of concept study in normal volunteers

Merson, L.; Olivier, N., 2002:
Orally active iron chelators

Dumas, J.; Hatoum Mokdad, H.; Sibley, R.N.; Smith, R.A.; Scott, W.J.; Lee, W.; Wood, J.; Wolanin, D.; Cooley, J.; Bankston, D.; Redman, A.; Schoenleber, R.; Caringal, Y.; Housley, T.J.; Wil, 2001:
Orally active p38 kinase inhibitors from the urea class

Nag, B.; Medicherla, S.; Dey, D., 1999:
Orally active peptides for the treatment of Type I and Late-Stage Type II diabetes

Wang, W.; Borchardt, R.T.; Wang, B., 2000:
Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists

Shimizu, Y.; Nagaya, N.; Satoh, T.; Uematsu, M.; Kyotani, S.; Sakamaki, F.; Nakanishi, N.; Miyatake, K., 2000:
Orally active prostacyclin analogue improves exercise capacity in patients with primary or thromboembolic pulmonary hypertension

Fraley, M.E.; Karki, S.B.; Kim, Y., 2003:
Orally active salts with tyrosine kinase activity

Pandey, B.; Balse, P.; Nag, A.; Gutala, S.; Neogi, P.; Nag, B.; Dey, D., 2004:
Orally active small molecule inhibitors of TNF- alpha and COX-2 for the treatment of Inflammatory disorders

Wright, J.; Boxer, P.; Gregory, T.; Huang, J.C.eng; Hong Bae, S.; Kaller, M.; Kesten, S.; Meltzer, L.; Upasani, R.; Whittemore, E.; Wise, L.; Woodward, R.; Yang, K.; Zhou, Z.L.n, 2000:
Orally active subtype-selective NMDA receptor antagonists for the treatment of Parkinsons disease

Chang, L.L.; Truong, Q.; Doss, G.; Lin, L.; Magriotis, P.A.; Maccoss, M.; Lyons, K.; Mccauley, E.; Mumford, R.A.; Van Riper, G.; Vincent, S.; Schmidt, J.A.; Hagmann, W.K., 2002:
Orally active, conformationally constrained small molecule VLA-4 antagonists

Dey, D.; Nag, A.; Pandey, B.; Gupta, A.; Sriram, S.; Agarwal, S.K.mar; Nag, B., 2003:
Orally active, small molecule TNFalpha inhibitor for the treatment of inflammatory disorders

Saslawski, O.; Giet, P.; Michel, D.; Holot, T., 2003:
Orally administerable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent

Maeda, N.Y.; Bydlowski, S.P.; Lopes, A.A., 1999:
Orally administered acetylsalicylic acid decreases protein incorporation into the cytoskeleton of thrombin-stimulated platelets

Mottet, N.; Bressolle, F.; Costa, P.; Chaufour, S.; Rauch, C.; M.C.rthy, C.; Magnier, G., 2000:
Orally administered alfuzosin has a high prostatic diffusion in benign prostatic hyperplasia tissue

Shulman, Morton, 2001:
Orally administered analgesic composition comprising myfadol

Hu, O.Y.a Pu; Hsiong, C.H.ei, 2004:
Orally administered analgesic compositions containing nalbuphine

Allendorf, D.J.; Baran, J.T.; Hansen, R.D.; Subbarao, K.; Walsh, D.; Hong, F.; Marroquin, J.; Yan, J.; Lambris, J.D.; Haribabu, B.; Ross, G.D., 2003:
Orally administered beta-glucan functions via anti-tumor mAbs and the complement system to recruit CR3+ neutrophils and macrophages that produce tumor regression and tumor-free survival

Macy, J.D.; Troiano, N.; Gundberg, C.; Gilligan, J.; Vignery, A., 1999:
Orally administered calcitonin prevents bone loss induced by ovariectomy in rats

Talwar, N.; Sen, H.; Staniforth, J.N., 2001:
Orally administered controlled drug delivery system providing temporal and spatial control

Lavi, I.; Levinson, D.; Peri, I.; Nimri, L.; Hadar, Y.; Schwartz, B., 2010:
Orally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis

Zhang, Y.; Rodell, T.; Murphy, T.M.; Robinson, C.E.; Banan, A.; Choudhary, S.; Keshavarzian, A., 2000:
Orally administered glutathione peroxidase-mimetic is a potent anti-oxidant Protection against oxidation and nitration of inflamed colonic mucosa in patients with ulcerative colitis

Opal, S.M.; Keith, J.C.; Palardy, J.E.; Parejo, N.A., 2000:
Orally administered human recombinant interleukin-11 microparticulates maintain intestinal mucosal integrity and decrease microbial invasion in experimental neutropenic sepsis

Musabayane, C.T.; Bwititi, P.; Munjeri, O.; Osim, E.E., 1999:
Orally administered pectin insulin hydrogel beads sustain insulin release in streptozotocin-diabetic rats

Fogelman, A.M.; Anantharamaiah, G.M.; Navab, M., 2003:
Orally administered peptides to ameliorate atherosclerosis

Lee, F.Y.; Chen, S.C.iung; Kuo, H.C.iang, 2001:
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same

Kawamura, Yukio, 1999:
Orally administered protein and innate immunity

Mali, S.; Gupte, R.; Deshpande, J.; Ranbhan, K., 2003:
Orally administrable acid stable antiulcer benzimidazole derivatives

Farah, N.; Denis, J., 2000:
Orally administrable composition capable of providing enhanced bioavailability when ingested

Tester, R.F.ank; Karkalas, J., 2003:
Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract

Gross, J.; Kelly, J.G.rard, 1999:
Orally administrable delivery device

Saslawski, O.; Giet, P.; Michel, D.; Holot, T., 2002:
Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent

Lee, F.Y.; Chen, S.C.iung; Kuo, H.C.iang, 2001:
Orally administrable nifedipine pellet and process for the preparation thereof

Oshlack, B.; Chasin, M., 1999:
Orally administrable opioid formulations having extended duration of effect

Liebowitz, S.M.; Stupak, E.I.; Chaudry, I.A.; Vadino, W.A.; Bowen, F.E., 2002:
Orally administrable solid dosage form

Liebowitz, S.M.; Stupak, E.I.; Chaudry, I.A.; Vadino, W.A.; Bowen, F.E., 2002:
Orally administrable solid ribavirin dosage forms and process for making them

Adeyeye, C.M.ji; Ichikawa, H.; Fukumori, Y., 2000:
Orally administrable time release drug containing products

Arimilli, M.N.; Dougherty, J.P.; Cundy, K.C.; Bischofberger, N., 1999:
Orally bioavailable acyclic nucleoside phosphonate prodrugs Adefovir Dipivoxil and Bis PMPA

Liu, M.; Bishop, W.R.; Nielsen, L.L.; Bryant, M.S.; Kirschmeier, P., 2001:
Orally bioavailable farnesyltransferase inhibitors as anticancer agents in transgenic and xenograft models

Pasternak, A.; Marino, D.; Vicario, P.P.; Ayala, J.M.; Cascieri, M.A.; Parsons, W.H.; Mills, S.G.; Maccoss, M.; Yang, L., 2003:
Orally bioavailable gamma-aminoamide CCR2 antagonists

Marquis, R.W.; Ru, Y.; Erhardt, K.F.; Gribble, A.D.; Witherington, J.; Fenwick, A.; Garnier, B.; Bradbeer, J.; Lark, M.; Gowen, M.; Tomaszek, T.A.; Tew, D.G.; Zhao, B.; Smith, W.W.; Janson, C.A.; D'alessio, K.J.; Mcqueney, M.S.; Abdel Meguid, S., 1999:
Orally bioavailable inhibitors of the cysteine protease cathepsin K

Siebert, J.M.; Khankari, R.K.; Kositprapa, U.; Pather, S.I.diran, 2002:
Orally disintegrable tablet forming a viscous slurry

Shimizu, T.; Morimoto, S.; Tabata, T., 2001:
Orally disintegrable tablets

Devries, T.; Valentine, W.; Valentine, W.K., 2002:
Orally dissolvable nutritional supplement

Kiszka, I.; Wierzbicki, A.; Kaneko, H.; Wasik, T.J.; Kaneko, Y.; Kozbor, D., 2000:
Orally induced mucosal and systemic immunity to the HIV envelope glycoprotein by prime-boost immunization strategies

Peet, N.P.; Angelastro, M.R.; Burkhart, J.P., 2001:
Orally-active elastase inhibitors

Hoekstra, William J., 2001:
Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders

Soos, J.M.; Schiffenbauer, J.; Johnson, H.M.rcellus, 2002:
Orally-administered interferon-TAU compositions and methods

Ohashi, K.; Kurimoto, M., 2001:
Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases

Quaglino, A.; Erichsen, A.L.; Craig Veit, C.B.; Viant, M.R.; Fry, D.M.; Millam, J.R., 1999:
Orally-dosed xenobiotic estrogens masculinize brain and behavior in the female zebra finch

Romero, F.A.; Silkoff, P.E.; Milgrom, H.; Townley, R.G., 2000:
Orally-exhaled nitric oxide correlates with serum IgE levels in children with atopic asthma

Lee, R.; Huber, K.; Roth, R.; Brunner, L.; E.H.san, A.; Cheung, J.; Bohner, B., 2002:
Orange County quick and easy asthma population management strategy

Goodner, K.L.; Manthey, J.A., 2001 :
Orange juice The naturally nutritious drink

Vanapalli, S.R.; Chen, Y.; Ellingrod, V.L.; Kitzman, D.; Lee, Y.; Hohl, R.J.; Fleckenstein, L., 2003:
Orange juice decreases the oral bioavailability of ivermectin in healthy volunteers

Lilja, J.J.; Juntti Patinen, L.; Neuvonen, P.J., 2003:
Orange juice greatly reduces plasma concentrations of celiprolol

Kurowska, E.M.; Spence, J.D.vid; Jordan, J.; Wetmore, S.; Freeman, D.J.; Piche, L.A.; Serratore, P., 1999:
Orange juice increases plasma HDL cholesterol and reduces the LDL/HDL cholesterol ratio in moderately hypercholesterolemic subjects

Cannon, B.; Jabeen, T.; Whelton, M.J., 2000:
Orange livers in Southern Ireland

Fan, K.; Kurihara, N.; Abe, S.; Yang, K.; Lipkin, M., 2003:
Orange peel extract inhibits intestinal tumor growth in ApcMin mice

Fambrini, M.; Michelotti, V.; Pugliesi, C., 2010:
Orange, yellow and white-cream: inheritance of carotenoid-based colour in sunflower pollen

Inacio, J.; Fonseca, A.; Spencer Martins, I., 2003:
Orange-pigmented yeasts from the phylloplane Taxonomic characterisation and direct molecular detection on leaves

Sutherland, Jamie P., 2001:
Orange-tip Anthocharis cardamines recorded from Brassica rapa

Van Schaik, C.P., 2003:
Orangutan cultures and the comparative study of culture

Macdonald, S.E.; Agnes, M.M., 1999:
Orangutan spatial memory and behavior in a foraging task

Van Schaik, C., 2001:
Orangutan traditions and their implications

Netter, M.; Schibli, R.; Scapozza, L.; Schubiger, A., 2003:
Oranometallic Re- and 99mTc-tricarbonyl-complexes of thymidine analogues Synthesis, structure-activity relationships, and biological evaluation

Ardies, C.M.rray; Karmali, R., 2001:
Orazamide orotate may attenuate doxorubicin induced lipid peroxidation and TNF content in heart

Viru, A.; Tipton, C.M., 2000:
Orbeli A Russian scientist to be remembered by exercise and cardiovascular physiologists

Mooney, M.; Weinberg, S.; Neiswanger, K.; Faix, R.; Richardson, D.; Petiprin, S.; Bardi, K.; Giles, R.; Carter, E.; Bowen, A.; Mazarita, M.L., 2002:
Orbicularis oris muscle morphology in individuals with cleft lip with or without cleft palate and their relatives

Bernardino, C.R.; Chang, E.L.; Fay, A.M.; Rubin, P.A.D., 2002:
Orbital Fractures Associated with Ocular Trauma - Clincal Features

Unal, M.; Konuk, O.; Atasever, T.; Ayvaz, G.; Yetkin, I.; Cakir, N.; Arslan, M.; Karakoc, A.; Egehan, I., 2000:
Orbital Gallium-67 scintigraphy A useful method to evaluate disease activity in Graves orbitopathy

Ahmed, S.; Fuchs, A.; Mehrotra, B., 2002:
Orbital Lymphomas A Single Institution Experience

Islam, N.; Mireskandari, K.; Rose, G., 2002 :
Orbital Varix And Wall Defects - Case Series

Engelman, C.J.; Palmer, J.D.; Egbert, P., 2004:
Orbital abscess following subtenon triamcinolone injection

Nishimura, T.; Koga, T.; Kobayashi, K.; Kobayashi, H.; Okinami, S.; Toda, S.; Sugihara, H., 2001:
Orbital adipocytes promote proliferation of corneal epithelial cells in reconstruction culture

Shepler, T.R.; Char, D.H., 2002:
Orbital and Eyelid Capillary Hemangiomas A Retrospective Look at 24 Consecutive Cases

Ray, S.K.; Hatton, M.P., 2001:
Orbital and adnexal trauma in open globe injuries

Guillou, L.; Coindre, J.M., 2000:
Orbital and extraorbital giant cell angiofibroma A giant cell-rich variant of solitary fibrous tumor

Colson, A.E.; Daily, J.P., 1999:
Orbital apex syndrome and cavernous sinus thrombosis due to infection with Staphylococcus aureus and Pseudomonas aeruginosa

Kurz, P.A.; Yung, R.; Harris, A., 2000:
Orbital blood flow pattern in patients with posterior ischemic optic neuropathy after surgery under general anesthesia

Fetkenhour, D.R.; Shields, C.L.; Chao, A.N.; Shields, J.A.; Guterman, C.B.; Eagle, R.C., 2001:
Orbital cavitary rhabdomyosarcoma masquerading as lymphangioma

Rachid, M.D.; Balli, F.; Carvalho, M.G.; Lucena, E.G.; Pinto, M.A., 2000:
Orbital cellulitis Review of 24 cases from a public health institution in Brazil

Kikkawa, D.O.; Heinz, G.W.; Martin, R.T.; Nunery, W.N.; Eiseman, A.S., 2002:
Orbital cellulitis and abscess secondary to dacryocystitis

Laviña, A.M.; Creasy, J.L.; Tsai, J.C., 2002:
Orbital cellulitis as a late complication of glaucoma shunt implantation

Morgan, S.J., 2003:
Orbital cellulitis following corneal gluing under sub-Tenon's local anaesthesia

Jacquemin, C.; Bosley, T.; Mullaney, P., 2000:
Orbital color Doppler imaging of optic nerve tumors

Trumpower, P.J., 1999:
Orbital convergence in small-bodies arboreal, nocturnal mammals Implications for primate origins

Rath, S.; Honavar, S.G.; Naik, M.; Anand, R.; Agarwal, B.; Krishnaiah, S.; Sekhar, G.Chandra., 2010:
Orbital cysticercosis: clinical manifestations, diagnosis, management, and outcome

Morse, S.A.; Callas, P.L.; Orth, G.A.; Frazier, A.G.C.; Chin, A.K., 1999:
Orbital dissection cannula and method

Sires, B.S.; Garwin, G.G.; Saari, J.C.; Hurst, J.S.; Van Kuijk, F.J., 2000:
Orbital fat Why the color difference?

Shiratori, C.A.; Schellini, S.A.; Marques, M.E.A.; Padovani, C.R., 2003:
Orbital fat histologic changes after experimental evisceration and enucleation

Hintschich, C.; Zonneveld, F.W.; Koornneef, L.Y., 2002:
Orbital fat in the acquired anophthalmic socket

Cochrane, S.R.; Hall, A.J.H.; Stawell, R.J., 2000:
Orbital floor steroids in non-necrotising scleritis

Hatton, M.P.; Watkins, L.M.; Rubin, P.A.D., 2000:
Orbital fractures in children A retrospective analysis

Putnam, K.M.; Pizzagalli, D.A.; Gooding, D.C.; Kalin, N.H.; Davidson, R.J., 2003:
Orbital frontal cortex activation and diurnal variation in cortisol evidence from brain electrical tomography analysis of high - density EEG data

Gözdaşoğlu, S.; Yavuz, G.; Unal, E.; Taçyldz, N.; Cavdar, A.O., 2002:
Orbital granulocytic sarcoma and AML with poor prognosis in Turkish children

Dareau, S.; Gros, T.; Bassoul, B.; Causse, L.; Eledjam, J.J., 2003:
Orbital haemorrhage after medial canthus episclera anaesthesia

Goldsmith, J.D.; Van D.R.jn, M.; Syed, N.A., 1999:
Orbital hemangiopericytoma and solitary fibrous tumor Lesions of similar pathogenesis?

Syed, N.A.; Goldsmith, J.D.; Van D.R.jn, M., 1999:
Orbital hemangiopericytoma and solitary fibrous tumor Neoplasms of similar pathogenesis?

Kaymaz, M.; Dogulu, F.; Kurt, Gökhan.; Kardes, Oür.; Baykaner, M.Kemali., 2002:
Orbital hydatid cyst. Case illustration